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Abstract 
The purpose of this work was to develop a sensitive in vitro method for ocular toxicity 
testing; and to use this method to assess the individual and combined effects of ophthalmic 
solutions, benzalkonium chloride (BAK), and ultraviolet (UV) radiation on the eye; as well 
as to investigate the detoxification of BAK in vitro.  
Using an in vitro test battery with immortalized human corneal epithelial cells (HCEC) 
and fluorescent dyes, the toxicity of differently preserved ophthalmic solutions was assessed 
in the first chapter of the thesis. The BAK-preserved solutions demonstrated the greatest 
adverse effect on HCEC, followed by the solutions with other preservatives. The 
preservative-free ophthalmic solution had the least adverse effect. The in vitro test battery 
demonstrated high sensitivity and good correlation with in vivo and clinical studies. 
PrestoBlue is a new resazurin-based reagent for assessing cell metabolic activity and 
cytotoxicity. The second chapter compared PrestoBlue, alamarBlue, and 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazonium bromide (MTT) in assessing cell viability of  
HCEC. The result showed that PrestoBlue was more sensitive than MTT, but similar to 
alamarBlue. The plate color, reading mode and plate storage up to 7 days did not affect the 
performance of the PrestoBlue assay. 
Using the in vitro test battery with the new reagent PrestoBlue, the third chapter assessed 
the individual and combined toxicity of UV radiation (UV A and UVB) and BAK on HCEC. 
The combined effects of UV plus BAK were either greater than (synergistic) or equal to 
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(additive) the sum of individual effects. The synergistic effects occurred between a low dose 
UV radiation (0.1719 J/cm²) and low concentrations (0.001%, 0.002%, 0.003% and 0.004%) 
of BAK. 
The last chapter investigated the detoxification of BAK by UVC radiation. The result 
showed that BAK toxicity on HCEC can be neutralized by an appropriate dose of UVC 
radiation. After complete neutralization, the toxicity of BAK was similar to phosphate 
buffered saline. While, the antimicrobial effect of BAK against Pseudomonas aeruginosa 
was reduced at the same time.   
The results of this work suggest that BAK-free, especially preservative-free ophthalmic 
solutions are safer alternatives to BAK-preserved ones. The combined toxic effects of BAK 
and solar radiation should be taken into consideration in the risk assessment of BAK-
preserved ophthalmic solutions. UVC radiation can be used to neutralize BAK toxicity. This 
detoxification may be of great value in utilizing the antimicrobial efficacy of BAK while 
minimizing its potential hazards. The in vitro test battery with cultured HCEC used for this 
research may provide a sensitive and meaningful approach for evaluating both individual and 
combined ocular toxicity of UV radiation and chemicals.  
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General Introduction 
The main goal of toxicological science is to protect humans from possible damage caused 
by a wide variety of substances. Human eyes are exposed to different insults throughout the 
day, such as solar ultraviolet (UV) radiation, air pollutants, personal hygiene products, skin 
care products, makeups, microorganisms, and ocular medications. Toxicity testing should be 
able to determine both the individual and combined effects of these insults to the eye.  
It is well known that the in vivo Draize test is the standard method of ocular toxicity 
testing accepted worldwide.
1
 However, in addition to ethical concerns, this test has been 
criticized increasingly on the basis of poor repeatability, poor sensitivity, and lack of 
objectivity. In order to reduce the use of animals in such experiments and to improve the 
ocular toxicity testing, there is a need to develop in vitro tests to replace the Draize test. 
Immortalized human corneal epithelial cell lines have been shown to be useful in the 
development of in vitro models for assessing ocular toxicity.
2-6
 Human corneal epithelial 
cells (HCEC) with the measurements of cell viability, membrane integrity, and cell growth 
are some of the assays that have been proposed as an alternative to the Draize test.
7,8
 
However, at present, no standard in vitro ocular toxicity method has been established.   
Eye drops are commonly used for the treatment of dry eye, ocular allergies, glaucoma 
and ocular infections. The inclusion of chemical preservative in these solutions is necessary 
to prevent contamination by microorganisms. However, ocular preservatives have been 
showed to cause damage to the eye.
9-11
 BAK, the most commonly used preservative, is a 
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well-known example. Numerous clinical studies have shown that BAK-preserved ophthalmic 
solutions can cause adverse effects on the eye.
12-14
 Extensive investigations involving clinical 
studies with patients,
12-14
 in vivo experiments with different animals,
15-17
 and in vitro tests 
using various cell culture systems
18-21
 have confirmed BAK’s toxicity to corneas and cultured 
cells at concentrations used clinically. Due to the toxic effect of BAK, new preservatives 
with less toxicity and similar antimicrobial capability are being developed and introduced 
into the market. Preservative-free ophthalmic solutions are also available. To assess the 
potential adverse effects of ophthalmic solutions on the eye, an in vitro test battery using 
HCEC and fluorescent dyes was developed. The validity of this test battery can be evaluated 
by its ability to predict toxicity as demonstrated from in vivo toxicology studies and clinical 
investigations.   
The assessment of cell viability plays an important role in toxicity testing. A wide range 
of assays based on various cell functions are available for cell viability detection. It is 
essential to choose the appropriate assay for the cell model and the type of toxic agents under 
evaluation. For example, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazonium bromide 
(MTT) and alamarBlue are two viability reagents that have been widely used in cell 
proliferation and cytotoxicity assessments. MTT mainly measures the mitochondrial 
dehydrogenate activity;
22
 while almarBlue is based on resazurin that functions as a cell 
viability indicator.
23,24
 Recently, a new reagent, PrestoBlue, has been brought into the 
market. It has the advantage of being water soluble, and non-toxic to cells;
24,25
 it is also 
claimed to be a fast and highly sensitive assay. At present, there is no report on the use of 
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PrestoBlue in cultures of human epithelial cells. To improve the sensitivity and efficiency of 
the in vitro test battery used in this work, this thesis compared PrestoBlue, alamarBlue, and 
MTT in assessing the cell viability of our cell model (HCEC), and investigated the effect of 
working conditions (plate color, reading mode, and plate storage) on the performance of the 
PrestoBlue assay. 
Human eyes are exposed to sunlight on a daily basis. Solar radiation includes UV 
radiation (100-400 nm), visible light (400-700 nm) and infrared radiation (700-10,000 nm).
26
 
UV radiation is subdivided into UVC (100-280 nm), UVB (280-315 nm), and UVA (315-400 
nm).
27
 The solar radiation at sea level consists of UVA and a small amount of UVB.
28
 
However, due to ozone depletion, the amount of hazardous UVB radiation reaching the 
Earth’s surface has increased in recent years, posing a higher risk for UV damage to the 
eye.
29
 UV radiation can damage DNA directly,
30,31
 decrease mitochondrial function,
32
 and 
induce apoptosis;
33
 it can also cause lipid peroxydation of cellular membranes through 
generation of free radicals.
34
 Increasing evidence has shown that UV exposure to the eye is 
associated with photokeratitis, pterygia, cataracts, and macular degeneration.
35
 
Many ophthalmic solutions containing preservatives are applied directly into eyes that are 
then exposed to sunlight; thus, a co-exposure of the cornea to ocular preservatives and solar 
radiation can occur. Such co-exposures may generate a toxic effect to the eye that is much 
greater than the sum of their individual effects. However, most risk assessments are based on 
the toxicity of individual compound or product formulations without a full consideration of 
the possible risks due to additional exposures to other toxic agents. Little attention has been 
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paid to the combined effects of ocular preservatives (such as BAK) and solar UV radiation 
on the eye. 
Mitigating the effect of toxic agents is of great importance in protecting humans from 
possible hazards. BAK is not only used as a preservative in ophthalmic solutions, but also 
widely used in various disinfectant formulations in the health care and food processing 
industries. As an ocular preservative, BAK causes adverse effects on the eye;
12-14
 similarly, 
as a disinfectant, BAK residue is toxic to humans and the environment,
36-39
 and can also 
contribute to bacterial disinfectant resistance.
40
 Some chemical compounds, such as high 
molecular weight hyaluronan,
41
 sodium hyaluronate,
42
 polyoxyethylene hydrogenated castor 
oil 40 (HCO-40) and polysorbate 80 (PS-80),
43
 have been proposed as BAK toxicity reducers 
in ophthalmic solutions. Nevertheless, little research has been done on eliminating the toxic 
effect of BAK and its residues in other applications. To the best of my knowledge, there is no 
report that UVC radiation can reduce the toxicity of BAK and its residues. 
The hypotheses of this dissertation include: 1) a sensitive in vitro method using HCEC 
can be developed for ocular toxicity testing; 2) this method developed can then be used to 
evaluate both the individual and combined effects of ophthalmic solutions, BAK and UV 
radiation on the eye; 3) the toxicity of BAK can be reduced by UVC radiation.  
To test these hypotheses, an in vitro test battery using HCEC with different bioassays was 
developed and used in evaluating the effects of ophthalmic solutions on the eye. The 
performances of three viability reagents on HCEC were compared, and the in vitro test 
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battery was confirmed by including a reagent that showed high sensitivity and efficiency. 
Using this in vitro method, the individual and combined effects of BAK and UV radiation on 
the eye were assessed; the detoxification of BAK using UVC radiation was also investigated.   
A detailed review of the literature dealing with the combined ocular toxicity of chemical 
mixtures and chemicals plus UV radiation was carried out as part of a graduate course (BIOL 
681, with Prof. D.G. Dixon), and is included as appendix A. 
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1.1 Overview  
Purpose: To investigate the effect of differently preserved ophthalmic solutions on the 
viability and barrier function of human corneal epithelial cells (HCEC) using fluorescent 
dyes. 
Methods: HCEC monolayers were exposed to the ophthalmic solutions containing 
benzalkonium chloride (BAK), edetate disodium (EDTA), polyquad, stabilized oxychloro 
complex (Purite), sodium perborate or sorbic acid for 5 min, 15 min, and 1 h. At 24 hours 
after exposure, the cultures were assessed for metabolic activity using alamarBlue. The 
enzyme activity, membrane integrity and apoptosis were evaluated using confocal 
microscopy. Barrier function was assessed using sodium fluorescein.   
Results:  The metabolic assay showed that the BAK-preserved ophthalmic solutions 
significantly reduced cell viability after 5 min exposure compared to the phosphate buffered 
saline treated control (p < 0.05). Using confocal microscopy, the micrographs showed that 
BAK-preserved solutions caused a reduction in enzyme activity, increased membrane 
permeability and decreased the number of viable cells. Ophthalmic solutions with new 
preservatives had varying time-dependent adverse effects on cell viability, and the 
preservative-free solution had the least effect on HCEC. Sodium fluorescein permeability 
showed that HCEC monolayers treated with BAK-preserved solutions were more permeable 
to sodium fluorescein than those treated by the other ophthalmic solutions (p < 0.05). 
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Conclusions: BAK-preserved solutions had greater adverse effect on metabolic activity, 
enzyme activity, membrane integrity, cell viability and barrier function than the solutions that 
were not preserved with BAK. Our study suggests that BAK-free, especially preservative-
free ophthalmic solutions are safer alternatives to BAK-preserved ones.  
 
  
 10 
 
1.2 Introduction 
The inclusion of preservatives in multiple-dose ophthalmic solutions is needed to prevent 
contamination by microorganisms. However, preservatives in ocular medications can cause 
damage to the corneal epithelium, and the long-term use of some preserved ophthalmic 
products has been associated with the occurrence of adverse changes to the ocular surface.
1-4
 
Benzalkonium chloride (BAK), the most commonly used preservative in ophthalmic 
solutions has been shown to cause ocular toxicity since 1944.
5
 In animal studies, BAK has 
been shown to cause damage to corneal epithelial cells. BAK caused swelling and 
desquamation of the rabbit corneal epithelial cells at a concentration of 0.005%.
6
 BAK also 
caused a progressive increase in damage to rabbit and cat corneas at concentrations between 
0.001% and 0.01%.
7
 In clinical studies, BAK-preserved ophthalmic solutions were also 
shown to cause tear ﬁlm instability (0.005% BAK),8 disruption of corneal barrier function 
(0.005% BAK),
9
 decrease of corneal sensitivity and reduction of the density of superﬁcial 
epithelial cells (0.01% BAK).
10
 Increasing evidence revealed that BAK is highly toxic, in a 
time- and dose-dependent manner, with a threshold of toxicity as low as 0.005%.
4,11-14
 
Due to the toxicity of BAK, considerable effort has been made to discover and develop 
new preservatives which have less toxicity but have similar capabilities of inhibiting 
microorganism growth in multiple-dose containers. Some new preservatives are 
commercially available, such as stabilized oxychloro complex (Purite), polyquad, sodium 
perborate and sorbic acid. Single-dose preservative-free ophthalmic solutions are also now 
available. 
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Several in vivo studies have compared the newer preservatives (Purite, polyquad, and 
sodium perborate) with BAK. Studies that investigated the effects of glaucoma medications 
on the cornea demonstrated that Purite-preserved eye drops were significantly more 
comfortable and showed less damage to the cornea than the BAK-preserved products.
4,15,16
 
Bernal and Ubels found that BAK containing eye drops caused rabbit corneas to become 
significantly more permeable to carboxyfluorescein than corneas treated with polyquad-
preserved eye drops.
17
 Labbe et al. also showed that polyquad 0.5% did not cause signiﬁcant 
changes in the ocular surface of rats compared to saline.
18
 Garcia-Valenzuela et al. studied 
the use of corneal lubricants during the course of vitrectomy surgery and determined that the 
sodium perborate maintained corneal clarity and epithelial integrity better than the lubricant 
that contained BAK.
19
 
In order to assess the potential damaging effects of the ophthalmic solutions on the 
cornea, an in vitro test battery using fluorescent dyes can be used. The validity of the test 
battery can be shown by its ability to predict toxicity as demonstrated from in vivo toxicology 
studies and clinical investigations. Due to the extensive data available on the harmful effects 
of BAK on the cornea in animal studies and in humans, the concentrations of 0.01%, 0.005%, 
and 0.001% were used as the positive controls in our investigation. Also, newer preservatives 
that have been shown to be less toxic from in vivo studies were used within our study as 
comparative controls due to the fact that they should show less toxicity to human corneal 
epithelial cells than BAK.  The aim of this study was to compare the relative toxicity of 
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commonly used eye drops and eye washes, and to demonstrate the utility of this in vitro 
battery for assessing the toxicity of ophthalmic products. 
1.3 Methods 
1.3.1 Chemicals and solutions 
Nine ophthalmic solutions including six dry eye drops and three eye washes were 
evaluated in this study. The solutions were purchased from commercial sources and were 
used within their labeled expiration dates. One solution (Visine) is preservative-free; five 
solutions (Systane, Refresh, GenTeal, ReNu, and Rite Aid) contain new preservatives; and 
three solutions (Akwa, Collyrium, and Optrex) contain BAK. Table 1-1 shows all the test 
solutions and their preservatives. Phosphate buffered saline (PBS) (Lonza, Walkersville, MD) 
was used as a negative control, and BAK 0.01%, BAK 0.005%, BAK 0.001% (CAS No. 
63449-41-2, Sigma-Aldrich St. Louis, MO) were used as positive controls. 
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Table 1-1. Test solutions and their preservatives 
Name of the Solution 
Full name (Abbreviation) Supplier Preservative 
Visine
®
 for dry eye Enduring Moisture
TM
 
(Visine) 
Johnson & Johnson Inc, Markham, 
ON None 
Systane
®
 Ultra Lubricant Eye Drops (Systane)  Alcon, Fort Worth, TX Polyquad 0.001% 
Refresh Tears
®
 Lubricant Eye drops (Refresh)  Allergan, Irvine, CA 
Stabilized oxychloro complex 
(Purite) 
GenTeal
®
 Artificial Tears(Genteal)  Novartis Mississauga, ON Sodium Perborate (GenAqua) 
ReNu Multiplus
®
 Lubricating Rewetting 
Drops (ReNu)  Bausch & Lomb, Rochester, NY 
Edetate disodium 0.1% and 
sorbic acid 0.1% 
Rite Aid Eye Wash (Rite Aid)  Rite Aid corporation, Camp Hill, PA 
Edetate disodium 0.025% and 
sorbic acid 0.1% 
Akwa Tears
®
 Lubricant Eye Drops (Akwa)  Akorn. Inc., Lake Forest, IL 
BAK 0.005% and edetate 
disodium 
Soothing Collyrium for FRESH EYES Eye 
Wash (Collyrium)  Bausch & Lomb, Rochester, NY BAK 0.01% 
Optrex
®
 Eye Wash (Optrex)  Reckitt Benckiser, Mississauga, ON BAK 
BAK: benzalkonium chloride 
 
 
1.3.2 Cell culture 
Human corneal epithelial cells (HCEC) were obtained from RIKEN BioResource Center, 
Tsukuba, Japan (#RCB 2280). It is a SV40-transformed human corneal epithelial cell line. 
The present study was performed with this cell line because it has good growth 
characteristics, shows a cobble-stone like appearance, develops good tight junctions, and it is 
free of infectious virus particles.
20-22
 The monolayers of the HCEC were prepared, with 
cultures that were less than 30 passages. 
The HCEC were cultured in DMEM/F-12 Ham Medium (Gibco Invitrogen, Grand Island, 
NY), with 10% fetal bovine serum (Gibco Invitrogen), and penicillin/streptomycin (Gibco 
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Invitrogen) in a humidified environment at 37 °C with 5% CO2. These cultures were 
maintained with weekly subculture using the Tryple Express (stable trypsin replacement; 
Gibco Invitrogen) and fed every 2 to 3 days. 
1.3.3 Assessment of metabolic activity 
A cell suspension (1 mL) containing 10
5
 cells was seeded in 24-well plates (BD Falcon, 
Franklin Lakes, NJ) and grown to approximately 75% to 80% confluent at 37 °C with 5% 
CO2. The cells were then exposed to test solution for 5 min, 15 min and 1 h. After exposure, 
the test solutions were removed and the cultures were rinsed with 1mL PBS. The cultures 
were then incubated for another 24 h in new culture medium at 37°C with 5% CO2.  
Following incubation, the medium was removed, and the well was rinsed with 1 mL PBS 
again. One mL of 10% alamarBlue (Invitrogen, Carlsbad, CA) prepared in medium without 
serum and phenol red was then added to each well and the cultures were incubated at 37 °C 
for 4 h. After incubation, the change in the fluorescence of the alamarBlue reagent (resazurin 
to resorufin) was measured using a SpectraMax fluorescence multi-well plate reader 
(Molecular Devices, Sunnyvale, CA) with the excitation/emission wavelengths set at 530/590 
nm. The few cells that detached from the plate surface after exposure to the test solution and 
PBS rinses were collected and assessed for viability using trypan blue. All experiments were 
done in triplicate.  
 15 
 
1.3.4 Confocal microscopy study with fluorescent viability dyes  
Confocal microscopy (Carl Zeiss LSM) with fluorescent viability dyes (calcein AM, 
ethidium homodimer-1 (EthD-1), and annexin V-Alexa Fluor 647 conjugate (annexin V); 
Invitrogen) were used to visualize live, dead, and apoptotic cells after exposure. Calcein 
changes to a fluorescent green molecule after reaction with intracellular enzymes in live 
cells; EthD-1 penetrates the compromised membranes and stains the nuclei of dead or dying 
cells; annexin V binds to phosphatidylserine (PS) on the outer surface of the cell membrane 
in apoptotic cells, and can stain PS in the interior of the cell membrane in dead cells. 
HCEC, 4×10
5
 cells in 1 mL of culture medium, were transferred into collagen coated 
glass bottom culture Petri dishes (MatTek Corp., Ashland, MA), and grown to confluence at 
37 °C with 5% CO2 for 2 days. The cultures were then exposed to test solution for 5 min, 15 
min, and 1 h. After exposure, the test solutions were removed, and the cultures were rinsed 
with 1mL PBS. New medium was then added into the dishes and the cultures were then 
incubated for another 24 h at 37 °C with 5% CO2. After incubation, the medium was 
removed from each Petri dish, and the dish was rinsed with 1 mL PBS again. The cells were 
then stained with annexin V (10 µl in 500 µl buffer), calcein AM (2 µM), and EthD-1 (4 µM) 
for 20 min at 37 °C. After staining, the fluorescence of the three dyes was then visualized 
with an Axiovert 100 microscope with a Zeiss confocal laser scanning microscope (CLSM) 
510 system. The excitation/emission wavelengths for calcein AM, EthD-1, and annexin V, 
were 495/515 nm, 528/617nm, and 650/665 nm, respectively. The natural color of annexin V 
fluorescence was red. However, in order not to confuse with the color of EthD-1 (which was 
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also red), we set the confocal software to present annexin V as yellow. We distinguished the 
cells according to the colors and locations of the three dyes. Live cells stain with calcein 
(green), and exclude annexin V (yellow) and EthD-1(red); dead cells stain with EthD-1 (red) 
in the nuclei and can stain with annexin V (yellow) in the interior of the cell membrane; 
apoptotic cells stain with annexin V (yellow) on the outer surface of the membrane and 
exclude EthD-1 (red).The percentage of live, dead and apoptotic cells in the confocal 
micrographs was calculated and compared. All experiments were done in triplicate.  
1.3.5 Assessment of barrier function  
 A cell suspension (0.5 mL) containing 10
5
cells was seeded in Millicell HA 13-mm 
inserts (Millipore, Bedford, MA). The inserts were then transferred into 24-well plates 
containing 0.5 mL of growth medium per well and incubated at 37°C with 5% CO2 for 7 
days. Medium was changed every day during that period. On day 7, each insert was gently 
rinsed three times with 1 mL of PBS using a 5-mL syringe without a needle and placed in a 
fresh 24-well plate. Then the cells were exposed to test solutions for 5 min, 15 min and 1 h. 
After exposure, the test solutions were removed and the inserts were rinsed with 3 mL PBS 
and placed in a fresh 24-well plate containing 0.5 mL of growth medium per well and fresh 
medium (0.5mL) was also added to the each cell insert. The cultures were incubated for 
another 24 h at 37 °C with 5% CO2. After incubation, each insert was individually rinsed 
three times with 1mL of PBS and placed in a fresh 24-well plates containing 0.5mL of PBS 
in each well. Sodium fluorescein (Sigma-Aldrich, St. Louis, MO; 0.5 mL; 3 mg/100 mL in 
PBS) was added to each insert. After a 20 minute incubation period the inserts were removed 
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from the wells and the amount of sodium fluorescein that penetrated through the cell 
monolayer was measured with a SpectraMax fluorescence multi-well plate reader (Molecular 
Devices, Sunnyvale, CA) at 485 nm excitation and 530 nm emission. All experiments were 
done in triplicate. Each series of triplicate samples was handled sequentially to allow the 
exact timing of the treatment and subsequent steps. 
1.3.6 Statistical analysis 
One-way ANOVA was used in the data analysis of this study. Pairwise multiple 
comparison procedures were performed using the Bonferroni post hoc test for the results of 
confocal microscopy study and the assessment of barrier function. The Games-Howell post 
hoc test was used for the results of metabolic activity tests because of the unequal variance of 
the data. The criterion of statistical significance was set to be p < 0.05. 
1.4 Results 
1.4.1 Measurement time points 
The toxicity of the test solutions was measured both immediately after exposure and at 24 
hours after exposure. However, the data at 24 hours after exposure was chosen because the 
toxicity increased with increasing concentrations of BAK and exposure time, which 
correlated well with in vivo data. Some other in vitro studies also used 24 hours post-
exposure time for ocular toxicity and irritation tests, and showed good correlations to in vivo 
studies.23-25 Therefore, this paper only shows the data at 24 hours after exposure.  
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1.4.2 Assessment of metabolic activity 
The effect of the test solutions on the cell viability of HCEC was measured using 
alamarBlue. The metabolic activity of the cells at 24 hours after exposure is shown in Figure 
1-1. The BAK-preserved ophthalmic solutions reduced cell viability to no more than 3% 
(compared to PBS) after 5 min and 15 min exposFures, which was significantly lower than 
all the other tested solutions without BAK (p < 0.05), and similar to BAK 0.01% and BAK 
0.005%. The BAK-free solutions had varying time-dependent adverse effects on cell viability 
after 5 min, 15 min and 1 h exposures. The preservative-free eye drop reduced cell viability 
significantly less than all the other products after 15 min, and 1 h exposures (p < 0.05). No 
significant differences were observed in the cell viability between Visine and the PBS control 
(p = 0.77) after 5 min exposure. Trypan blue exclusion test with manual cell count showed 
that less than 10 % of the cells being washed away were live cells (Data not shown). 
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Figure 1-1. Viability of HCEC using alamarBlue.   
Cell viability at 24 hours after exposure to the test solutions was measured using alamarBlue. 
Significantly different from all the preserved ophthalmic solutions (p < 0.05) is indicated by 
a red asterisk (*).  Significantly different from all BAK-free ophthalmic solutions after 5 min 
and 15 min exposure (p < 0.05) is indicated by a purple asterisk (*). Error bars: ± SD.  
  
 20 
 
1.4.3 Confocal microscopy study with fluorescent viability dyes 
The confocal microscopy with fluorescent viability dyes showed the cell viability of the 
cultures at 24 hours after exposure to the test solutions. Figure 1-2, Figure 1-3, and Figure 1-
4 are representative confocal laser scanning micrographs. Cell size may vary depending on 
whether the cells adhered to the culture dish or not. The counts of live, dead and apoptotic 
cells in confocal laser scanning micrographs are shown in Figure 1-5. Mean counts were 
made using 3 separate cultures that are treated with each solution. In all the time points, 
BAK-preserved solutions showed significantly more cell death compared to the BAK-free 
solutions and the PBS control (Figure 1-2, 1-3, 1-4, and 1-5, p < 0.05). After 5 min exposure, 
Akwa had the least cell toxicity among the solutions with BAK (Figure 1-2 and 1-5, p < 
0.05). After 1 h exposure, the preservative-free solution caused the least amount of cell death 
among all the test solutions (p < 0.05); Refresh reduced the cell viability the most among all 
the solutions with new preservatives (p < 0.05); and the BAK-preserved solutions caused 
100% cell death (Figure 1-4 and 1-5). 
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Figure 1-2. Representative confocal laser scanning micrographs of HCEC at 24 hours after 5 
min exposure. 
The effect of the test solutions is shown on the distributions of live, dead, and apoptotic cells 
in the culture. Live cells are calcein (green) - positive, annexin V (yellow) - negative, and 
EthD-1(red) – negative; dead cells are EthD-1 (red) - positive; apoptotic cells are annexin V 
(yellow) - positive and EthD-1 (red) – negative. In the first row are the controls; in the 
second row are the Preservative-free solution (Visine) and the BAK-preserved solutions; and 
in the third row are the solutions which contain new preservatives. The yellow arrow 
indicates live cells; the blue arrows show cells in apoptosis; the purple arrows indicate dead 
cells. Bar = 50 µm. All the micrographs use the same magnification.  
Controls 
PBS BAK 0.001% BAK 0.005% BAK 0.01% 
Preservative 
free solution 
and BAK-
preserved 
solutions 
Visine Akwa Collyrium Optrex 
Solutions 
with new 
preservatives 
Systane Refresh Genteal ReNu Rite Aid 
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Figure 1-3. Representative confocal laser scanning micrographs of HCEC at 24 hours after 15 
min exposure. 
The effect of the test solutions is shown on the distributions of live, dead, and apoptotic cells 
in the culture. Live cells are calcein (green) - positive, annexin V (yellow) - negative, and 
EthD-1(red) – negative; dead cells are EthD-1 (red) - positive; apoptotic cells are annexin V 
(yellow) - positive and EthD-1 (red) – negative. In the first row are the controls; in the 
second row are the Preservative-free solution (Visine) and the BAK-preserved solutions; and 
in the third row are the solutions which contain new preservatives. Bar = 50 µm. All the 
micrographs use the same magnification. 
Controls 
PBS BAK 0.001% BAK 0.005% BAK 0.01% 
Preservative 
free solution 
and BAK-
preserved 
solutions 
Visine Akwa Collyrium Optrex 
Solutions 
with new 
preservatives 
Systane Refresh Genteal ReNu Rite Aid 
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Figure 1-4. Representative confocal laser scanning micrographs of HCEC at 24 hours after 1 h 
exposure. 
The effect of the test solutions is shown on the distributions of live, dead, and apoptotic cells 
in the culture. Live cells are calcein (green) - positive, annexin V (yellow) - negative, and 
EthD-1(red) – negative; dead cells are EthD-1 (red) - positive; apoptotic cells are annexin V 
(yellow) - positive and EthD-1 (red) – negative. In the first row are the controls; in the 
second row are the Preservative-free solution (Visine) and the BAK-preserved solutions; and 
in the third row are the solutions which contain new preservatives. Bar = 50 µm. All the 
micrographs use the same magnification.  
Controls 
PBS BAK 0.001% BAK 0.005% BAK 0.01% 
Preservative 
free solution 
and BAK-
preserved 
solutions 
Visine Akwa Collyrium Optrex 
Solutions 
with new 
preservatives 
Systane Refresh Genteal ReNu Rite Aid 
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Figure 1-5. The counts of cells in the confocal laser scanning micrographs. 
The results are expressed as a percentage of the cells. The percentages of live cells in the 
BAK-preserved solutions were significantly lower than those in the BAK-free solutions after 
5 min, 15 min and 1 h exposures (p < 0.05).  *: significantly different from the other BAK-
preserved solutions (p < 0.05); α: significantly different from the BAK-preserved solutions 
and the solutions with new preservatives (p < 0.05); ∆: significantly different from all the 
other solutions with new preservatives (p<0.05). 
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1.4.4 Assessment of barrier function 
The effect of the test solutions on corneal tight junctional integrity was assessed using 
sodium fluorescein. Figure 1-6 shows the results for all the test solutions at 24 hours after 
exposure. There was no significant difference in fluorescein permeability between PBS 
control and BAK-free ophthalmic solutions after 5 min, 15 min and 1 h exposure. However, 
BAK-preserved solutions acted differently. Collyrium Eye Wash (contains BAK 0.01%) 
showed significantly greater fluorescein permeability than all the other products and the PBS 
control after 15 min exposure (p < 0.013). All BAK-preserved products showed remarkably 
greater fluorescein permeability than the PBS control and all the BAK-free products after 1 h 
exposure (p < 0.001) (Figure 1-6).  
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Figure 1-6. Barrier function of HCEC at 24 hours after 5 min, 15 min, and 1 h exposures using 
the sodium fluorescein permeability measurement. 
The results are expressed as a percentage of the permeability of the PBS control. The greater 
percentage of permeability compared to the PBS control represents the more sever loss of 
integrity of the culture. Significantly greater than PBS control (p < 0.05) is indicated by an 
asterisk (*). Error bars: ± SD. 
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1.5 Discussion 
The results of this study demonstrate that BAK-preserved solutions had significantly 
greater adverse effect on cell viability and tight junctions than the eye drops and eye washes 
that do not contain BAK. The in vitro test battery correlated well with in vivo studies and 
clinical studies which showed that BAK-preserved eye drops caused ocular toxicity at 0.01% 
and 0.005% concentrations,4,6,8-11,13,14,18,26,27 and with in vivo comparison studies showing that 
the products without preservatives or with newer preservative caused less damage to the 
ocular surface than BAK-preserved products.4,18 
BAK has been the most commonly used preservative for topical ophthalmic medications 
used by clinicians. Its use is aimed at preventing contamination of multiple-dose containers. 
However, BAK does have adverse effects, which may be more apparent under conditions of 
long term use. It has been consistently shown to be toxic to ocular tissue in clinical and 
experimental studies.1,4,8-14,28-35 To develop less toxic alternatives to BAK, new preservatives 
such as polyquad, stabilized oxychloro complex (Purite), sodium perborate and sorbic acid 
have been proposed and are commercially available. A few studies have evaluated the 
cytotoxicity of these new preservatives.4,15,16,18,36 Our results show that the preservatives 
polyquad, Purite, sodium perborate and sorbic acid did not cause obvious cell toxicity after 
short exposure (5 min, and 15 min), and were significantly less toxic than the solutions with 
BAK, which is consistent with the previous in vivo and clinical studies.4,15,18 Nevertheless, we 
also found that the solutions with new preservative had a time-dependent toxicity to cultured 
HCEC. They caused mild to moderate degrees of toxicity after 1 h exposures. This was not 
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shown in the previous in vivo toxicity or clinical studies. In addition, compared to the 
products with BAK and new preservative, the preservative-free solution consistently showed 
least toxicity in our study and in all the previous studies.8,9,28,35,37,38 
AlamarBlue is designed to quantitatively measure the proliferation of various human and 
animal cell lines. It incorporates a fluorescent growth indicator based on the detection of 
metabolic activity. The innate metabolic activity of the viable cells results in a chemical 
reduction of alamarBlue (also called resazurin), which causes it to change from oxidized 
form (non-fluorescent, blue) to reduced form (fluorescent, red).39 AlamarBlue is non-toxic to 
cells. A decrease in the alamarBlue fluorescence readings indicates the decrease of metabolic 
activity (the viability) of the cultured cells. In the present study, cells exposed to BAK-
preserved ophthalmic solutions showed a significant reduction in metabolic activity 
compared to the PBS treated control, and the BAK-free solutions (Figure 1-1). Preservative-
free eye drops caused the least reduction of metabolic activity in the tested ophthalmic 
solutions. This suggests that among the ophthalmic solutions used in this study, the BAK-
preserved solutions are the most, and preservative-free solution is the least toxic to cultured 
HCEC. In addition, according to our results, the assessment of metabolic activity of HCEC 
with alamarBlue is very sensitive to the toxicity of preservative. It showed remarkable cell 
toxicity of the BAK-preserved ophthalmic solutions after only 5 min exposure, and showed 
differences between the solutions with and without BAK, as well as with and without 
preservative after only 15 min exposure. 
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Cell viability after exposure was also analyzed in this study using confocal microscopy 
with fluorescent viability dyes. The dyes are calcein AM, EthD-1, and annexin V for 
detecting live, dead and apoptotic cells, respectively. Calcein AM can penetrate live cells. 
Because of the intracellular esterase activity of the live cells, the nonfluorescent calcein AM 
is then converted to the intensely fluorescent calcein, which stains the intracellular cytoplasm 
and produce an intense uniform green fluorescence in live cells.40 EthD-1 is excluded by the 
intact plasma membrane of live cells. However, nonfluorescent EthD-1 enters cells with 
damaged membranes, and binds to the nucleic acids, which enhances the fluorescence and 
produces a bright red fluorescence in dead cells.40 Annexin V is a phospholipid-binding 
protein that has a high affinity for phosphatidylserine (PS). In normal viable cells, PS is 
located on the cytoplasmic surface of the cell membrane. However in apoptotic cells, PS is 
translocated from the inner to the outer leaflet of the plasma membrane. Annexin V can bind 
to PS exposed on the outer leaflet and then the fluorescence can be detected.41,42 Annexin V 
can also penetrate the compromised membranes of dead cells and stain PS in the interior of 
the cell. The three fluorescent dyes calcein AM, EthD-1, and annexin V can be used together 
due to the non-overlapping emission spectra and different binding sites of these molecules. 
Thus, we can show the distributions of live, dead and apoptotic cells of the culture in the 
same micrograph of the culture. In the present study, the results were similar to alamarBlue 
study. After 5 min exposure to the BAK-preserved ophthalmic solutions, the cultures showed 
an obvious increase of apoptotic cells and dead cells as well as cell loss. On the contrary, the 
cultures of the BAK-free solutions looked similar to the PBS control after 5 min exposure 
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(Figure 1-2 and 1-5). As the exposure time increased from 5 min to 1 h, the amount of 
apoptotic cells and dead cells increased in all the cultures except the PBS controls: the most 
in the solutions with BAK (100% cell death), and the least in the preservative-free solution 
(Figures 1-3, 1-4 and 1-5). This confirmed the result of the alamarBlue evaluation: BAK-
preserved solutions are the most toxic to the cultured HCEC, followed by the solutions with 
new preservative, and the preservative-free solution is the least toxic. In addition, the 
comparison of the cell counts in the confocal micrographs indicated that, among the three 
BAK-preserved solutions, Akaw was the least toxic at 5 min exposure, and among the five 
solutions with new preservatives, Refresh was the most toxic at 1 h exposure.   
Tight junctions are an important characteristic of healthy human corneal epithelium. 
Sodium fluorescein permeability can be used to detect the loss of tight junctions and defects 
of integrity in corneal epithelium. It measures sodium fluorescein leakage. The more 
fluorescein leakage indicates the more loss of tight junctions and the more defects of 
integrity. This method has been used in many studies to measure damage to corneal  
tissue.43-46 Our study also used it to detect damage of the barrier function caused by 
ophthalmic solutions. Again, the BAK-preserved solutions were shown to cause the greatest 
loss of integrity of the culture, followed by the solutions with new preservative. The 
preservative-free solution caused the least damage to the barrier function. This assay was not 
as sensitive as the alamarBlue assay and confocal microscopy study with fluorescent viability 
dyes. We didn’t find a significant difference in fluorescein permeability between PBS control 
and BAK-free ophthalmic solutions after 5 min, 15 min and 1 h exposures (Figure 1-6). This 
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may be due to the age of the culture (1 - 2 days for the alamarBlue and confocal microscope 
study vs. 7 days in the fluorescein permeability assessment). Also, because the cells in the 
fluorescein permeability assessment were grown for 7 days, the cells may have been more 
tightly opposed to each other and therefore the surface area exposed to the chemical was less 
than the other two studies where the cells were not as dense. 
 In order to see the potential toxicity of all the test solutions, we use three different time 
points. In our results, the difference between the solutions with and without BAK was shown 
after 5 min exposure in the metabolic assay and confocal microscopy study with fluorescent 
viability dyes (Figures 1-1,1- 2 and 1-5); and after 1 h exposure in the measurement of 
barrier function (Figure 1-6). The difference between the preservative-free product and those 
with new preservatives was shown after 15 min exposure in the metabolic assay (Figure 1-1) 
and after 1 h exposure in confocal microscopy study with fluorescent viability dyes (Figure 
1-4 and 1-5), but was not shown in the measurement of barrier function. The dis-concordance 
among the metabolic assay, confocal microscopy study and measurement of barrier function 
indicates that the toxicity which causes a reduction in the cell metabolic activity may not 
cause cell death; and the effect on cell viability may not cause the disruption of tight 
junctions at low toxicity levels. Therefore, in order to have a better understanding and obtain 
a better assessment of the toxicity of an agent, we need to combine several assays together, 
and analyze the toxic effect from different aspects. 
One limitation of this study is that we evaluated the toxic effect of whole commercial 
ophthalmic solutions instead of their components. Typical formulations contain active 
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components and additives such as preservatives and buffers. We could not identify the 
individual effects of the components in this study. We know the toxicity is mainly caused by 
the preservative, but the other components may increase or decrease the effect. Further 
investigations of individual components are necessary to fully understand the toxicity of the 
ophthalmic solutions. 
Dry eye is a common disease that affects a patient’s quality of life and may require long-
term treatment with eye drops. BAK in eye drops may aggravate dry eye disease. It has been 
shown that BAK can cause goblet cells loss, meibomian gland disruption and tear ﬁlm 
instability.8,27 Symptoms of BAK toxicity that include irritation, dry eye, foreign body 
sensations and blurred vision have been shown to decrease signiﬁcantly by switching from a 
BAK-preserved formulation to a preservative-free one.8,9,38 Due to the increased sensitivity of 
corneal epithelial cells in dry eye patients from the reduced flow of tears, preservatives such 
as BAK in eye drops may present a considerable problem for long-term use by patients with 
dry eyes. We recommend that clinicians consider solutions without preservative, or at least 
without BAK, especially for the patients who have compromised ocular surface where 
damage of corneal epithelium by preservatives is suspected. Because of single-dose 
packaging, it may be costly to use preservative-free ophthalmic solutions. However it will 
provide significant benefit to patients, especially those with a compromised ocular surface 
and a need for the long term use of topical medications. 
In summary, the present study clearly revealed that the tested commercial ophthalmic 
solutions are less cytotoxic with new preservative than with BAK; and without preservative 
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than with new preservative. Our study suggests that BAK-free and preservative-free 
ophthalmic solutions are safer alternatives to BAK-preserved ones. The results of this study 
also demonstrated that cytotoxicity of the ophthalmic solutions can be evaluated using 
cultured HCEC with three different assays: the metabolic assay using alamarBlue, confocal 
microscope study with fluorescent viability dyes, and measurement of barrier function using 
sodium fluorescein. 
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The next chapter compared the performances of three reagents – PrestoBlue, alamarBlue 
and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazonium bromide (MTT), in assessing cell 
viability of human corneal epithelial cells in vitro, and investigated the effect of working 
conditions (plate color, reading mode, and plate storage) on the performance of the 
PrestoBlue assay. 
 
This is a methodology study witch was done to investigate whether PrestoBlue is an 
appropriated reagent for the cell model used in this thesis work.  
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2.1 Overview 
Introduction: PrestoBlue is a new resazurin-based reagent to assess cell viability and 
cytotoxicity. It is claimed to be a fast and highly sensitive assay. Here, we compared 
PrestoBlue, alamarBlue, and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazonium bromide 
(MTT) in assessing cell viability of human corneal epithelial cells (HCEC), and investigated 
the effect of plate color, reading mode, and plate storage on the performance of PrestoBlue 
assay. 
Methods: The viability of different numbers of healthy HCEC and the toxicity of various 
chemicals on HCEC were evaluated using PrestoBlue (fluorescence), alamarBlue 
(fluorescence), and MTT (absorbance). The sensitivities of the three assays were compared. 
In the PrestoBlue assay, three plate colors and two reading modes were used and compared in 
assessing the toxic effect of SDS. The PrestoBlue solutions after reaction were stored and 
measured on day 1, 2, 3, 5, and 7. The fluorescence readings obtained on different days were 
then compared. 
Results: Both PrestoBlue and alamarBlue were able to detect 5000 healthy cells after 30 
min incubation and 1000 cells after 1h, 2h, and 4h incubation; while MTT was able to detect 
5000 cells after 3h incubation. In the assessment of the toxicity of various chemicals, 
PrestoBlue and alamarBlue performed similarly. There was no significant difference between 
the results obtained by these two reagents. All the three plate colors and two reading modes 
 37 
 
showed similar results in the PrestoBlue assay in assessing the toxicity of SDS. Plate storage 
up to 7 days did not affect the result of the PrestoBlue assay.   
Conclusion: Our study suggests that in evaluating the viability of HCEC, PrestoBlue is 
more sensitive than MTT, but similar to alamarBlue. The plate color, reading mode and plate 
storage up to 7 days did not affect the performance of the PrestoBlue assay.  
2.2 Introduction 
The measurement of cell viability plays an essential role in the toxicity testing. It is a 
fundamental tool for screening new drugs and chemicals, and provides initial data prior to 
performing in vivo and clinical studies. A wide range of assays are available for cell viability 
detection. They are based on various cell functions such as mitochondrial enzyme activity, 
cell membrane permeability, ATP production, and cellular uptake activity. The viability 
assays chosen for assessment in our study are based on mitochondrial enzyme activity. Three 
reagents were compared here: PrestoBlue, alamarBlue, and MTT.  
The MTT assay has been widely used in cell viability and cytotoxicity tests since it was 
first introduced by Mosmann in 1983.1-5 This assay relies on a reductive coloring reagent 
(tetrazolium salt) and the mitochondrial dehydrogenase activities to determine cell viability 
with a colorimetric method.3 In viable cells, MTT is reduced mainly by NADH to an 
insoluble purple formazan, which forms crystals in cells. After crystal formation, an organic 
solvent is used to dissolve the purple crystals and absorbance is measured to assess the 
viability of target cells. 
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Both almarBlue and PrestoBlue are based on resazurin which functions as a cell viability 
indicator.6,7 In viable cells, resazurin is reduced to resorufin in cellular respiration by 
accepting electrons from NADPH, FADH, FMNH, NADH and cytochromes.8 This reduction 
causes PrestoBlue and alamarBlue to change from non-fluorescent form to strong fluorescent 
form.9 The conversion is proportional to the number of metabolically active cells and can be 
evaluated quantitatively using fluorescence or absorbance measurements.10,11 Both 
alamarBlue and PrestoBlue are water soluble, non-toxic to cells and hence are less likely to 
interfere with normal metabolism and allow further usage of the cells in subsequent test.11 
Although both reagents are resazurinbased, PrestoBlue is a newer product and is claimed to 
have several advantages over alamarBlue and other viability reagents. According to the 
manufacturer supplied data, PrestoBlue measured cell viability in an incubation time as short 
as 10 min, and was able to detect 12 Jurkat cells after 16 h incubation using fluorescence 
measurement, which means that it is a faster assay with higher sensitivity. However, there is 
no information available on how PrestoBlue differs from alamarBlue in terms of the 
mechanism or chemical reaction. The only information we were able to obtain from the 
manufacturer is that the buffers in these two reagents are different, while the details of the 
difference, how it affects the chemical reaction and performance of the reagent are 
proprietary. 
Since the PrestoBlue assay is a highly sensitive assay, in order to obtain the optimum 
result, selecting the proper plate and the correct reading mode is of great importance. 
Different plates have different reflective properties. Black plates absorb light, reduce 
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background fluorescence and minimize well-to-well crosstalk. White plates reflect light 
and maximize output signal. Clear plates are favorable in cell culturing studies because they 
enable microscopy applications to examine the cells during the experiments, and allow top 
and bottom reading capabilities. Top reading offers better signal-to-noise ratios for solution-
based assays; while bottom reading provides higher fluorescence signal and can preserve the 
sterility of the well contents by allowing the cover to be left on the plate during reading. 
What kind of plate (black, white or clear) and reading mode (top or bottom reading) gives 
better result for the PresotBlue assay? How does the plate color and reading mode affect the 
performance of the assay? To the best of our knowledge, no study has been done to address 
these questions.  
Not all investigators have fluorescence plate reader. It may be difficult to read plates right 
after experiments. According to the manufacturer of PrestoBlue reagent, assay plates can be 
wrapped in foil, stored at 4°C, and read within 1-3 days. However, will a longer storage of 
the plates affect the result of the PrestoBlue assay? Is there a new way to store the plates for 
delayed measurements without affecting the result? As far as we know, there is no report on 
these questions.  
To date, there are three studies that compared PrestoBlue with other similar viability 
reagents in assessing the viability of different parasites12,13 and microorganisms.14 However, 
for the application in human cells, only one study conducted by Boncler compared 
PrestoBlue and MTT in evaluating the viability of human endothelial cells.15 The aim of this 
study was to compare the sensitivity of PrestoBlue, alamarBlue, and MTT in assessing cell 
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viability of human corneal epithelial cells (HCEC), and to investigate the effect of plate 
color, reading mode and plate storage on the performance of the PrestoBlue assay. 
For these purposes we used PrestoBlue, alamarBlue and MTT to assess the viability of 
different numbers of healthy HCEC and to evaluate the toxicity of various chemicals on 
HCEC. In the fluorescence measurement of the PrestoBlue assay, three plate colors and two 
reading modes were used, and the plates were stored and measured up to 7 days.   
2.3 Methods 
2.3.1 Chemicals and solutions 
Four chemicals with different concentrations were tested in this study: benzalkonium 
chloride (BAK) (Sigma-Aldrich, St. Louis, MO), Ethylenediaminetetraacetic acid disodium 
salt (EDTA) (Sigma-Aldrich, St. Louis, MO), Polyaminopropyl biguanide (PAPB) 
(Lotioncrafter, Olga, WA), and sodium dodecyl sulfate (SDS) (Sigma-Aldrich, St. Louis, 
MO). PrestoBlue and alamarBlue were purchased from Invitrogen, Carlsbad, CA. MTT was 
purchased from Sigma-Aldrich, St. Louis, MO.  
2.3.2 Cell culture  
Human corneal epithelial cells (HCEC) were obtained from RIKEN BioResource Center, 
Tsukuba, Japan (#RCB 2280). It is a SV40-transformed human corneal epithelial cell line. 
The monolayers of the HCEC were prepared with cultures that were less than 10 passages to 
ensure the consistency among experiments. The HCEC were cultured in DMEM/F-12 1:1 
Media (Hylcone, Thermo Scientific, South Logan, Utah), with 10% fetal bovine serum 
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(Gibco Invitrogen), and 1% penicillin/streptomycin (Gibco Invitrogen) in a humidified 
environment at 37 °C with 5% CO2. These cultures were maintained with weekly subculture 
using the Tryple Express (stable trypsin replacement; Gibco Invitrogen) and fed every 2 to 3 
days. 
2.3.3 MTT assay   
The assay was carried out in 96-well plates (BD Falcon, Franklin Lakes, NJ). Each well 
contained the cells to be tested with cultured medium or rinsing solution removed. 100 ul 
MTT solution (1mg/ml in clear medium without serum and phenol red) was added to each 
well and the plates were incubated at 37°C for 3 hours. During the incubation, the active 
enzymes of the viable cells transformed the yellow MTT into purple formazan crystals. The 
top medium was then removed and isopropanol was added to each well to dissolve the 
formazan crystals. The absorbance of the solution was determined at 570nm by a SpectraMax 
fluorescence multi-well plate reader (Molecular Devices, Sunnyvale, CA). 
2.3.4 AlamarBlue assay and PrestoBlue assay  
The assays were carried out in either 96-well or 24-well plates (BD Falcon, Franklin 
Lakes, NJ). Each well contained the cells to be tested with cultured medium or rinsing 
solution removed. 100 ul (for 96-well plates) or 1 ml (for 24-well plates) alamarBlue or 
PrestoBlue solution (10% in medium without serum and phenol red) was added to each well 
and the plates were incubated at 37 °C for a specified time period. After incubation, 100 ul of 
the alamarBlue or PrestoBlue solution from each well of the assay plates (96-well plates or 
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24-well plates) was transferred to a new well in 96-well plate, and the change in the 
fluorescence of the test reagent (resazurin to resorufin) was measured in the new plate using 
a SpectraMax fluorescence multi-well plate reader with the excitation/emission wavelengths 
set at 530/590 nm for alamarBlue and at 560/590 nm for PrestoBlue.  
2.3.5 Assessment of healthy cells  
Cell suspension (100ul) containing different numbers of healthy HCEC ranging from 20 
to 50,000 was seeded in 96-well plates and allowed to attach and stabilize overnight at 37 °C 
with 5% CO2. Then the cell viability was tested using either (a) MTT with 3 h incubation, or 
(b) alamarBlue with 4 different incubation times: 30 min, 1 h, 2 h, and 4 h, or (c) PrestoBlue 
with 4 different incubation times: 30 min, 1 h, 2 h, and 4 h. The ability of the three assays in 
detecting the viability of healthy HCEC was evaluated and compared. Another test was 
carried out to see whether the cell numbers at the time of measurement are different from the 
cell numbers seeded. Different numbers of cells (50, 100 and 500, n=8 in each group) were 
seeded in a 96-well plate and incubated overnight. The numbers of the cells adhered in each 
well were then counted the next morning (the same time that the measurements were carried 
out). One sample T-test was done to compare the actual cell counts to the cell numbers 
seeded. 
2.3.6 Assessment of the toxicity of different chemicals  
Four chemicals with different concentrations were tested: BAK 0.001%, BAK 0.01%, 
EDTA 0.01%, EDTA 0.02%, PAPB 0.0001%, PAPB 0.001%, SDS 0.01%, and SDS 0.05%.  
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1 ml of cell suspension with 10
5
cells was seeded in 24-well plates and grown to 
approximately 80% confluent at 37 °C with 5% CO2. The cells were then exposed to test 
solution for 5 min. After exposure, the test solutions were removed, the cultures were rinsed 
with 1 ml PBS and then the cell viability of the culture was tested using alamarBlue and 
PrestoBlue with 1 h incubation. The ability of the two assays in differentiating the 
cytotoxicity of various chemicals was compared. 
An additional test was done to further assess the ability of PrestoBlue and almarBlue in 
evaluating the toxicity of EDTA on HCEC. The viability of HCEC cultures after exposure to 
5 concentrations of EDTA (0.01%, 0.05%, 0.1%, 0.5% and 1%) was tested using PrestoBlue 
and alamarBlue with the same method described in the previous paragraph. 
2.3.7 Effect of plate color and reading mode on the performance of PrestoBlue 
assay  
 One milliliter of cell suspension with 10
5
cells was seeded in 24-well plates and grown to 
approximately 80% confluent at 37 °C with 5% CO2. The cells were then exposed to 6 
concentrations of SDS (0.5%, 0.1%, 0.05%, 0.02%, 0.01% and 0.005%) for 5 min. After 
exposure, the SDS solutions were removed and the cultures were rinsed with 1 ml PBS. 1 ml 
PrestoBlue solution (10% in medium without serum and phenol red) was then added to each 
well and the plates were incubated at 37 °C for 1 h. After incubation, 300 µl of PrestoBlue 
solution from each well of the assay plates was transferred and divided equally into 3 wells 
(100 µl/well) in 3 types of 96-well plates (white, black, and clear plate). The change in the 
fluorescence of the test reagent was measured in the 3 types of plates, with 2 reading modes 
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in the clear plates (top reading and bottom reading). The excitation/emission wavelengths 
were set at 560/590 nm. The measurements obtained by different plates and reading modes 
were compared.  
2.3.8 Effect of plate storage on the measurement of PrestoBlue assay 
In order to prevent unwanted reduction of PrestoBlue reagent (resazurin) by the cells 
during the plate storage, we separated the PrestoBlue solutions from the cells by transferring 
the solutions to new 96-well plates after incubation. The plates were then fully covered to 
prevent evaporation, wrapped in foil to protected from light, and kept at 2 - 8 °C for 7 days. 
The fluorescence of the plates was measured before storage on day 1, and during the storage 
on day 2, 3, 5, and 7. All the measurements were made at room temperature (22°C) and were 
compared to the reading on day 1.  
2.3.9 Statistical analysis  
All experiments were done in quadruplicate. One-way ANOVA followed by the 
Bonferroni post hoc test was used in the data analysis in the assessment of healthy cells. In 
the assessment of the toxicity of different chemicals and the comparison of different plates 
and reading modes, one-way ANOVA and the Games-Howell post hoc test were performed 
because of the unequal variance of the data. Pearson’s correlation was used in analyzing the 
effect of plate storage on measurements. The criterion of statistical significance was set to be 
p < 0.05. 
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2.4 Results 
2.4.1 Assessment of healthy cells   
Our result showed no significant difference between the actual cell counts at the time of 
measurement and the cell numbers seeded (52.05 ± 8.18 vs. 50, p = 0.501; 98.96 ± 4.93 vs. 
100, p = 0.281; and 498.44 ± 16.46 vs. 500, p = 0.797). Therefore, the cell numbers seeded 
represented the cell counts at the time of measurements.  
The number of viable, healthy HCEC cells was measured using PrestoBlue, alamarBlue 
and MTT. The results are shown in Figure 2-1 (PrestoBlue), Figure 2-2 (alamarBlue) and 
Figure 2-3 (MTT). All of the 3 assays showed good dose response of fluorescent/absorbance 
value to the cell numbers. As the cells number increased, the fluorescence/absorbance 
increased. In both the PrestoBlue and alamarBlue assays (Figure 2-1 and Figure 2-2), 
significantly higher fluorescent value compared to the control with no cells was detected in 
≥5000 cells after 30 min incubation and in ≥1000 cells after 1 h, 2 h, and 4 h incubation (p ≤ 
0.027). The MTT assay was not able to detect 1000 cells at 3 hour incubation (p = 0.171). 
The MTT assay only showed significantly higher absorbance for ≥5000 cells vs the control 
with no cells after 3 h incubation (p < 0.001) (Figure 2-3). 
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Figure 2-1. Viability of healthy HCEC measured by PrestoBlue. 
Error bars: ±SD. *Significantly different from the control with no cells after 30 min, 1 h, 2 h, 
and 4 h incubation, p ≤ 0.018. # Significantly different from the control with no cells after 1 
h, 2 h and 4 h incubation, p ≤ 0.023. 
 
 
*    *    * # 
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Figure 2-2. Viability of healthy HCEC measured by alamarBlue. 
Error bars: ±SD. *Significantly different from the control with no cells after 30 min, 1 h, 2 h, 
and 4 h incubation, p ≤ 0.027. # Significantly different from the control with no cells after 1 
h, 2 h and 4 h incubation, p ≤ 0.021. 
# *     *     * 
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Figure 2-3. Viability of healthy HCEC measured by MTT. 
Error bars: ±SD. *Significantly different from the control with no cells after 3 h incubation, p 
< 0.001. 
 
2.4.2 Assessment of the toxicity of different chemicals 
Based on the results in the assessment of healthy cells, 1 h, 2 h, and 4 h incubations had 
the same sensitivity in the Prestoblue and alamarblue assays. Therefore, we used 1h 
incubation in our following tests. MTT was shown to be less sensitive and hence we only 
compared PrestoBlue and alamarBlue.  
The toxicity of four different chemicals was assessed using PrestoBlue and alamarBlue. 
Results are shown in Figure 2-4 and Figure 2-5. Again, these two assays performed similarly. 
* 
* 
* 
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According to the results of both assays, BAK, PAPB and SDS showed dose-dependent 
cytotoxicity on HCEC. SDS 0.05% was the most toxic, followed by BAK 0.01%, SDS 
0.01%, BAK 0.001% and PAPB 0.001%. All of them significantly reduced the cell viability 
compared to the medium control (p ≤ 0.012.). There is only one difference between the two 
assays. PrestoBlue was able to show significant difference between EDTA (both 0.01% and 
0.02%) and the medium control (p = 0.026 and 0.035, respectively), while alamarBlue did 
not (p = 0.335 and 0.126, respectively).  
An additional test was done to further assess the ability of PrestoBlue and almarBlue in 
evaluating the toxicity of EDTA on HCEC. In the additional test, PrestoBlue and alamarBlue 
also performed similarly in evaluating the toxicity of EDTA 0.01%, 0.05%, 0.1%, 0.5% and 
1% (Figure 2-6 and Table 2-1). The cell viabilities obtained by the two reagents were in good 
agreement with each other. Both assays showed a dose response on EDTA toxicity, with the 
highest cell viability obtained in EDTA 0.01% (85.40 ± 2.90 with PrestoBlue and 86.28 ± 
3.88 with alamarBlue) and the lowest obtained in EDTA 1% (71.26 ± 2.09 with PrestoBlue 
and 70.70 ± 3.30 with alamarBlue). All the five concentrations of EDTA (0.01%, 0.05%, 
0.1%, 0.5% and 1%) significantly reduced the cell viability compared to the medium control 
(p = 0.001~0.005). There was no significant difference between the results of the two assays 
(p = 0.730).   
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Figure 2-4. Viability of HCEC after 5-min exposure to different chemicals measured by 
PrestoBlue. 
Error bars: ±SD. *Significantly different from the medium control, p ≤ 0.035. ∆Significantly 
different from each other: BAK 0.001% vs. BAK0.01%; PAPB 0.0001% vs. PAPB 0.001% 
and SDS 0.01% vs. SDS 0.05%, p ≤ 0.007. 
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Figure 2-5. Viability of HCEC after 5-min exposure to different chemicals measured by 
alamarBlue. 
Error bars: ±SD. *Significantly different from the medium control, p ≤ 0.012. ∆Significantly 
different from each other: BAK 0.001% vs. BAK 0.01%; PAPB 0.0001% vs. PAPB 0.001% 
and SDS 0.01% vs. SDS 0.05%, p ≤ 0.021. 
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Figure 2-6. Viability of HCEC following EDTA treatment measured by PrestoBlue and 
alamarBlue. 
Error bars: ±SD. *Significantly different from the medium control, p = 0.001~0.005. 
 
Table 2-1. Viability of HCEC after exposure to EDTA mesured by PrestoBlue and 
alamarBlue. 
Reagent 
EDTA Concentration 
0.01% 0.05% 0.10% 0.50% 1% 
PrestoBlue 85.40 ± 2.90 83.97 ± 2.72 81.48 ± 3.23 73.59 ± 3.98 71.26 ± 2.09 
AlamarBlue 86.28 ± 3.88 82.47 ± 3.68 80.08 ± 4.65 74.12 ± 5.71 70.70 ± 3.30 
Results are calculated in percentage of medium control and expressed as Mean ± SD.  
EDTA, Ethylenediaminetetraacetic acid disodium salt; HCEC, human corneal epithelial cells.  
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2.4.3 Effect of plate color and reading mode on the performance of PrestoBlue 
assay 
The viability of HCEC after 5-min exposure to 6 concentrations of SDS was evaluated 
using PrestoBlue with three different colors of plates (white, black, and clear) and two 
reading modes in the clear plates (top reading and bottom reading). Figure 2-7 A shows the 
raw fluorescence reading of the four different test conditions. White plate with top reading 
mode had significantly higher raw fluorescence readings compared to all the other test 
conditions (all p < 0.001). There was no significant difference among clear plate with bottom 
reading, clear plate with top reading and back plate with top reading (all p > 0.05). For a 
further comparison, we subtracted the blank and calculated the percentage of cell viability 
compared to the medium control. The result is shown in Figure 2-7 B. In all the test 
conditions, all of the 6 concentrations of SDS (0.02%, 0.05%, 0.1%, 0.5%, 0.005% and 
0.01%) were significantly different from the medium control (p ≤ 0.017); both SDS 0.005% 
and 0.01% had significantly higher cell viability compared to SDS 0.02%, 0.05%, 0.1% and 
0.5% (p < 0.001). There was no significant difference in among the cell viability obtained in 
the four test conditions (all p > 0.05).  
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Figure 2-7. Effect of plate color and reading mode on the measurement of PrestoBlue assay. 
The viability of HCEC after 5-min exposure to 6 concentrations of SDS was tested using 
PrestoBlue with 3 types of plates and 2 reading modes. Figure 2-7 A shows the raw 
fluorescence readings. Figure 2-7 B shows the result after the readings were subtracted by the 
∆ 
∆ 
∆ 
∆ 
∆ ∆ ∆ ∆ 
A 
B 
* * * * 
* # 
* a 
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blank and compared to the medium control. Error bars: ±SD. ∆Significantly higher than the 
corresponding readings in the other test conditions, p < 0.001. * Significantly different from 
the medium control in all test conditions, p < 0.017. a: Significantly different from SDS 
0.01%, SDS 0.02%, SDS 0.05%, SDS 0.1% and SDS 0.5% in all test conditions, p < 0.001.  
#: Significantly different from SDS 0.02%, SDS 0.05%, SDS 0.1% and SDS 0.5% in all test 
conditions, p < 0.001.  
 
2.4.4 Effect of plate storage on the measurement of PrestoBlue assay 
In the PrestoBlue assay, the fluorescence readings obtained on day 2, 3, 5, and 7 after 
sampling were compared to the reading obtained on day 1. Pearson’s correlation analysis 
showed great linear correlations between the reading on day 1 and all the readings on day 2, 
3, 5 and 7 (Figure 2-8, R
2
 = 0.998 ~ 0.999, all p < 0.001).  
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Figure 2-8. Effect of Plate Storage on the Measurement of PrestoBlue Assay. 
Pearson’s correlation between the fluorescence readings on day 1 and day 2, 3, 5, and 7. A: 
Day 2 vs. Day 1; B: Day 3 vs. Day 1; C: Day 5 vs. Day 1; D: Day 7 vs. Day 1. R
2
 = 0.998 ~ 
0.999, all p < 0.001. 
 
2.5 Discussion 
MTT, alamarBlue and PrestoBlue are all viability reagents based on mitochondrial 
enzyme activity. The first two reagents have been used widely in cell proliferation and 
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cytotoxicity assessments.16-20 PrestoBlue is a new reagent recently brought into the market. 
Similar to alamarBlue, it is resazurin-based, water soluble, and non-toxic to cells.7,15 
However, it is claimed to be a fast and highly sensitive assay. According to the manufacturer 
supplied data, it could assess cell viability with 10 min incubation, and was able to detect as 
few as 12 Jurkat cells. So far, there are four studies which validated the use of PrestoBlue in 
different types of cells, one in microorganisms,14 two in parasites,12,13 and one in human 
endothelial cells.15 To the best of our knowledge, there is no report on the use of PrestoBlue 
in cultures of human epithelial cells; neither there is any study on the effect of plate color, 
reading mode and plate storage on the performance of the PrestoBlue assay. 
In our study, the sensitivity of MTT, PrestoBlue and alamarBlue in evaluating the 
viability of healthy HCEC was compared. Since PrestoBlue was claimed by the manufacturer 
to be able to detect as few as 12 cells, a wide range of cell numbers (from 20 to 50,000) was 
used in our test. Not only did it cover the smallest magnitude of cells that PrestoBlue was 
claimed to detect, it also included the magnitude of cells that are commonly used in cell 
viability evaluation. This enabled us to better explore the sensitivity of the three assays.    
When tested in 96-well plates, PrestoBlue and alamarBlue were able to detect 5000 cells 
after 30 min incubation and 1000 cells after 1 h, 2 h, and 4 h incubation; while MTT was 
only able to detect 5000 cells after 3 h incubation. This indicates that PrestoBlue and 
alamarBlue are more sensitive than MTT, or when the same sensitivity is achieved (detecting 
5000 cells), PrestoBlue and alamarBlue are faster assays (30 min incubation vs. 3 h 
incubation). There are two possible reasons. First, MTT mainly measures the mitochondrial 
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dehydrogenate activity,3 and is reduced primarily by oxidoreductase enzymes, the majority of 
which utilize NADH.21 On the other hand, PrestoBlue and alamarBlue involve more 
mitochondrial enzymes and accept electrons from NADPH, FADH, FMNH, NADH, and also 
from cytochromes.8 Besides, MTT formazan is insoluble in cell culture media and forms 
purple needle-shaped crystals in cells. The culture media has to be removed and an organic 
solvent is required to dissolve the crystals before measuring the absorbance.3 However, it is 
difficult to remove the culture media due to many floating cells with MTT formazan needles. 
This gives significant well-to-well error, increases the standard deviation, and eventually 
decreases the assay sensitivity. On the contrary, PrestoBlue and alamarBlue are soluble in 
culture media.6 No solubilizing process is required, and hence this simplifies the assays and 
reduces error. What is more, PrestoBlue and alamarBlue are non-toxic to cells, which allows 
the assayed cells to be used in subsequent test;6,7 while MTT assay can only be used as an 
end-point procedure because it kills the cells by forming crystals.3 Based on the reasons 
above, PrestoBlue and alamarBlue are considered superior to MTT.  
Our result is in contrast to a study by Boncler et al.
15
 They compared PrestoBlue and 
MTT in assessing the anti-proliferative effects of plant extracts on confluent human vein 
endothelial cells and found that MTT assay had lower inter-assay variability and higher 
signal-to-noise ratio compared to PrestoBlue assay.15 Vascular endothelial cells are 
particularly sensitive to cell contacts and undergo rapid inhibition of cell proliferation by 
cellular confluence.22,23 As a result, there was a notable difference in the cell proliferation 
between the cells tested in Boncler’s study and our study (confluent vascular endothelial cells 
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vs. non-confluent corneal epithelial cells), which would affect the results of PrestoBlue and 
MTT assays.  
Although PrestoBlue is claimed to be a faster assay with higher sensitivity, it performed 
similarly to alamarBlue in evaluating the viability of healthy HCEC. In order to further 
compare these two assays, a second test (assessment of the toxicity of different chemicals on 
HCEC) was conducted. Again, these two reagents performed similarly. Therefore, an 
additional test was carried out to further assess these two assays in evaluating the toxicity 
EDTA on HCEC. Once more, PrestoBlue and alamarBlue performed similarly. There was no 
significant difference between the results obtained by the two assays (p = 0.730). This 
suggests that in evaluating the viability of HCEC, PrestoBlue and alamarBlue are 
comparable. This is not surprising. Similar result was reported by one recent study. Carmen 
et al. compared PrestoBlue and alamarBlue directly using absorbance and ﬂuorescence 
measurements and concluded that these two reagents were equally useful in evaluating the 
viability of Acanthamoeba.13 Nevertheless, Lall et al. used PrestoBlue for antimicrobial 
analysis against different microorganisms and found that it was faster than alamarBlue as a 
viability indicator for Streptococcus mutans, Prevotella intermedia, and Mycobacterium 
tuberculosis.14 The different results obtained in different studies indicate that in evaluating 
different organisms and cell lines, PrestoBlue performed differently.    
In the current study, we also investigated the effect of plate color and reading mode on 
the performance of the PrestoBlue assay using fluorescence measurement. Four test 
conditions were compared: white plate with top reading, black plate with top reading, clear 
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plate with top reading, and clear plate with bottom reading. They were judged based on their 
performances in assessing the cytotoxicity of six concentration of SDS on HCEC. As 
expected, white plate with top reading mode had significantly higher raw fluorescence 
readings compared to all the other test conditions (all p < 0.05) (Figure 2-7 A). However, top 
reading mode and bottom reading mode in clear plate had very similar raw fluorescence 
signals. The possible reason is that the particular clear bottom plastic in this type of clear 
plate gave very little autofluorescence at the emission wavelength (590nm) used in this 
experiment. More unexpectedly, after subtracting the blank control and calculating the 
percentage of viability compared to the medium control, all four test conditions showed very 
similar results (Figure 2-7 B). There was no significant difference in the sensitivity among 
the four different test conditions. This suggests that with the proper controls (blank and 
negative/positive controls) to minimize the effect of background noise, the three different 
plates and two reading modes perform similarly in the PrestoBlue assay in assessing the cell 
viability of HCEC. This may broaden the plate selection for PrestoBlue.    
Sometimes, it is difficult to read a plate right after an experiment is performed. It would 
be helpful if plates can be stored and read a few days later without affecting the result. It is 
recommended by the manufacturer that plates can be refrigerated, wrapped in foil and read 
within 1-3 days. They also suggest stopping and stabilizing the reaction by adding 3% SDS 
to the cells for an end-point assay.10 However, there is a disadvantage in storing plates with 
cells under test. The metabolic activity of the cells can reduce resazurin during the storage. 
With high cell numbers and prolonged storage, over-reduction of resazurin may occur and 
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produce an uncolored, nonfluorescent product (hydroresorufin), leading to artefact results.24 
In our study, one more procedure was added to improve the result of the stored plates. We 
separated the PrestoBlue solutions from the cells by transferring the solution to new 96-well 
plates which were then stored for further measurements. This prevented unwanted reduction 
of PrestoBlue reagent (resazurin) during the plate storage, and what is more, saved the cells 
for further culturing and subsequent test. In the current study, the plates without cells were 
stored up to 7 days and fluorescence readings were obtained on day 1, 2, 3, 5, and 7 after 
sampling. There were great linear correlations between the readings on day 1 and all the 
readings on day 2, 3, 5 and 7 (Figure 2-8, R
2
 = 0.998 - 0.999, all p < 0.001). This is a 
promising finding. It indicates that plates without cells can be saved up to 7 days without 
affecting the result. It increases the flexibility of the PrestoBlue assay and offers more 
convenience to the investigators, especially for those who share one fluorescence plate reader 
with many people. There is one thing to keep in mind while taking measurements with stored 
plates. Because fluorescence measurements are influenced by temperature, the plates should 
be warm to the temperature at which the readings are normally taken.    
In summary, our study suggests that in evaluating the viability of HCEC, PrestoBlue is 
more sensitive than MTT, but similar to alamarBlue. When fluorescence measurement was 
used, the plate color, reading mode and plate storage up to 7 days did not affect the 
performance of the PrestoBlue assay.  
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According to the results of Chapter 2, PrestoBlue is a fast and sensitive viability reagent 
that also offers flexibility and great convenience to investigators. This finding confirms the 
use of PrestoBlue in the in vitro cell model.  
Using this cell model, the next chapter assessed the individual and combined toxicity of 
ultraviolet radiation and BAK on human corneal epithelial cells. 
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3.1 Overview 
Purpose:  To investigate the combined effect of benzalkonium chloride (BAK) and 
ultraviolet (UV) radiation on cultured human corneal epithelial cells (HCEC), and to analyze 
whether there is any additive or synergistic effect between UV radiation and BAK.  
Methods: Cultured HCEC were exposed to BAK alone, UV alone, or BAK plus UV. The 
exposure of UV plus BAK was evaluated using three different protocols to evaluate the 
possible effect of the exposure order: a) UV and BAK simultaneously, b) UV 1
st
 and BAK 
2
nd
, c) BAK 1
st
 and UV 2
nd
. After exposure, cell metabolic activity was measured with 
PrestoBlue, and cell viability was determined using confocal microscopy with viability dyes. 
To test for photoreactivity, BAK solutions were treated by UV radiation, and the cell toxicity 
of the UV-treated BAK on HCEC was measured with PrestoBlue. Phosphate buffered saline 
(PBS) was used as a negative control.   
Results: BAK alone reduced the metabolic activity and cell viability of HCEC in a dose- 
and time-dependent manner. UV alone at a low dose (0.1719 J/cm²) had little toxicity on 
HCEC and showed similar effect to the PBS control. However, when the cultures were 
treated with UV plus BAK, the combined effects were either greater than (synergistic) or 
equal to (additive) the sum of individual effects. The synergistic effects occurred between the 
low dose UV radiation and low concentrations (0.001%, 0.002%, 0.003% and 0.004%) of 
BAK. In the test for photoreactivity, UV-treated BAK had similar or slightly lower cell 
toxicity than the untreated BAK.  
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Conclusions: Our study indicates that co-exposure to UV radiation and BAK can cause 
synergistic and additive effects on human corneal epithelial cells. This finding highlights the 
importance of considering the combined toxic effects of BAK and solar radiation in the risk 
assessment of BAK-preserved ophthalmic solutions. 
3.2 Introduction 
Chemical preservatives are used in a variety of ophthalmic solutions to prevent 
contamination by microorganisms, and many ophthalmic solutions containing preservatives 
are instilled directly into eyes that are then exposed to sunlight. Therefore, co-exposure of the 
cornea to preservatives and solar radiation can occur. Such exposure might result in greater 
toxicity to the cornea. A combination of two toxic agents may produce synergistic or additive 
effects. A synergistic effect occurs when the combined effect of two agents is greater than the 
sum of their individual effect (e.g., 1+1=10); while, an additive effect takes place when the 
combined effect is equal to the sum of the effects of each agent given alone (e.g., 1+1=2).  
Benzalkonium chloride (BAK), a quaternary ammonium cationic surfactant, is the most 
commonly used preservative in ophthalmic solutions. Numerous clinical studies have shown 
that BAK-preserved ophthalmic solutions can cause damage to the eye, such as tear film 
instability,1 disruption of corneal barrier function,2 and reduction of corneal sensitivity.3 In 
addition, in vivo studies with animals and in vitro studies with various cell lines have also 
demonstrated that BAK alone is toxic to animal corneas and cultured cells at concentrations 
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used clinically.4-9 Based on in vivo and in vitro studies, BAK is highly toxic in a time- and 
dose-dependent manner, with a toxicity threshold as low as 0.005%.10-14 
The ambient UV radiation at the Earth’s surface consists mainly of UVA (315–400 nm) 
radiation and a small amount of UVB (280–315 nm) radiation.15 However, due to the ozone 
depletion, the amount of hazardous UVB radiation reaching the Earth’s surface has increased 
recently,16 posing a higher risk for UV damage to the eye. There is some evidence that the 
ozone layer is recovering due to the reduction in ozone depleting chemicals; however, it is 
estimated that a complete recovery will not occur until the year 2100.17  Strong evidence has 
revealed that acute high dose exposure to UV radiation causes photokeratitis and 
photoconjunctivitis.18,19 Also, considerable epidemiological and experimental evidence 
indicates that chronic exposure to UV radiation is a major risk factor for cataract, pterygium, 
and age-related macular degeneration.18-20  
Co-exposure to preservatives and UV radiation may generate a toxic effect to the eye that 
is much greater than the sum of their individual effects. Withrow et al.21 tested the mutagenic 
potential of four ocular preservatives in mouse lymphoma cells with and without UVA 
radiation. They reported that chlorhexidine alone had little mutagenic potential, but when 
combined with UVA, there was approximately a threefold increase over background in the 
number of mutants; also, the mutagenic activity of thimerosal was significantly enhanced in 
combination with UVA. Another study conducted by Lovely et al. investigated the combined 
effect of preservatives and visible light in bacterial systems. In this study, thimerosal was 
found to cause DNA damage only under conditions of illumination; while BAK showed 
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genetic toxicity in darkness, and this toxicity was enhanced in conjunction with exposure to 
visible light.22 Although BAK has been shown to be synergistic with gentamicin in causing 
disruption to corneal epithelial cells,23 to the best of my knowledge, no studies have reported 
any synergistic effect between BAK and UV radiation on human ocular cells.   
The aim of this study was to investigate the combined toxicity of BAK and UV radiation 
(UVA and UVB) on human cornea epithelial cells and to analyze whether there is any 
additive or synergistic effect between BAK and UV radiation. For this purpose, the effect of 
BAK alone, UV alone, and BAK plus UV on cultured human corneal epithelial cells (HCEC) 
was assessed and compared. The toxicity of different treatments was measured using two in 
vitro assays including PrestoBlue and confocal microscopy with viability dyes. 
3.3 Materials and Methods 
3.3.1 Materials 
Human corneal epithelial cells (HCEC) were purchased from RIKEN BioResource 
Center, Tsukuba, Japan (#RCB 2280). This cell line was chosen for this study because it has 
good growth characteristics, shows good tight junctions, and is free of infectious virus 
particles.24-26 DMEM/F-12 Ham Medium, fetal bovine serum, penicillin/streptomycin, Tryple 
Express, PrestoBlue, calcein AM, ethidium homodimer-1 (EthD-1) and annexin V-Alexa 
Fluor 647 conjugate (annexin V) were obtained from Life Technologies Inc. (Burlington, 
ON). Cell culture plates (24-well plates) were purchased from BD Falcon (Franklin Lakes, 
NJ). Collagen coated glass bottom culture Petri dishes were from MatTek Corp. (Ashland, 
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MA). Phosphate buffered saline (PBS) was obtained from Lonza (Walkersville, MD). 
Benzalkonium chloride (BAK, 10%) was purchased from Sigma-Aldrich (St. Louis, MO), 
and was diluted in PBS into five lower concentrations (0.001%, 0.002%, 0.003%, 0.004% 
and 0.005%) for the use of this study.   
3.3.2 Cell culture 
The HCEC were grown in DMEM/F-12 Ham Medium with 10% fetal bovine serum and 
1% penicillin/streptomycin in a humidified environment at 37 °C with 5% CO2. These 
cultures were maintained with weekly subculture using Tryple Express and fed every 2 to 3 
days. The monolayers of HCEC were prepared with cultures that were less than 10 passages 
in order to ensure consistency among experiments. 
3.3.3 Cell treatments and measurement time points 
There were three different treatments in this study: 1) UV alone, 2) BAK alone, 3) UV 
plus BAK. The treatment of UV plus BAK was evaluated using three different protocols for 
the order of the addition of UV and BAK: a) UV and BAK simultaneously, b) UV 1
st
 and 
BAK 2
nd
, c) BAK 1
st
 and UV 2
nd
.  
The cultures were assessed for metabolic activity using PrestoBlue immediately after 
treatment (0h), as well as at 1 h, 2 h, 4 h and 8 h after treatment. Cell viability was examined 
using confocal microscopy with viability dyes at 2 h after exposure. In order to test for the 
photoreactivity of BAK, one additional experiment was conducted. In this experiment, BAK 
solutions were pre-treated with UV radiation for 5 min. Then cell cultures were exposed to 
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the UV-treated BAK for 10 min. At 0 h, 1 h, 2 h, 4 h and 8 h after exposure, the cultures 
were tested for metabolic activity with PrestoBlue. In all the experiments, PBS was used as a 
negative control.  
3.3.4 UV irradiation  
UV exposure was conducted in a custom designed UV irradiation unit at 37 °C with 5% 
CO2. The UV source used in this study was two UV fluorescence tubes (Microlites Scientific, 
Toronto, ON) that emit broadband UVA and UVB (280-400 nm). Before irradiation, the 
irradiance of the UV source was measured with an USB 2000+ fiber optic spectrometer 
(Ocean Optics, Inc. Dunedin, FL). The result is shown in Figure 3-1. The calculated 
irradiance was 5.73 W/m
2
. Samples were exposed to UV radiation at a distance of 30 cm 
from the light source for 5 min (the corresponding dose was 0.1719 J/cm²). During UV 
radiation, the samples were covered with quartz to prevent evaporation; a thin layer of 
solution (1.5 mm) was left above the cells to minimize absorption of the radiation by the 
solution. When the culture was exposed to UV and BAK simultaneously, the thin layer of 
solution was BAK solution; otherwise, it was PBS solution. In the photoreactivity test, a thin 
layer (1.5 mm) of BAK solution was exposed to UV without cells. The solutions were 
covered with quartz during UV radiation.  
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Figure 3-1. Spectrum of the UV source measured with an USB 2000+ fiber optic spectrometer. 
The calculated irradiance was 5.73 W/m
2
. 
 
3.3.5 BAK exposure   
BAK (10%) purchased from Sigma-Aldrich was diluted in PBS into lower concentrations 
for the use of this study. Cell cultures were exposed to various concentrations of BAK with 
or without UV radiation. Based on the concentrations of BAK commonly used in ophthalmic 
solutions and on the results of our preliminary tests (data no shown), five concentrations of 
BAK were used in this study: 0.001%, 0.002%, 0.003%, 0.004% and 0.005%. After 
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removing growth medium from the cultures, a thin layer of BAK solution (1.5 mm) was 
placed above the cells. The cultures were then incubated at 37 °C with 5% CO2 for 10 min. 
Following the incubation, BAK solutions were removed and the cultures were rinsed with 1 
ml of PBS.  
3.3.6 PrestoBlue assay  
One ml of cell suspension containing 10
5
 cells was seeded in 24-well plates and grown to 
approximately 75% to 80% confluent at 37 °C with 5% CO2. The cells were then exposed to 
various treatments. Cell metabolic activity was assessed with PrestoBlue immediately after 
treatment, as well as at 1 h, 2 h, 4 h, and 8 h after treatment. At every time point, each well 
contained the cells to be tested with cultured medium or rinsing solutions removed. One ml 
of 10% PrestoBlue reagent prepared in medium without serum and phenol red was added to 
each well and the cultures were incubated at 37 °C for 1 h. Following incubation, the change 
in the fluorescence of the PrestoBlue reagent (resazurin to resorufin) was measured using a 
SpectraMax fluorescence multi-well plate reader (Molecular Devices, Sunnyvale, CA) with 
the excitation/emission wavelengths set at 560/590 nm. Between time points, PrestoBlue was 
removed; the cultures were rinsed with 1 ml of PBS and incubated with fresh culture medium 
at 37 °C with 5% CO2. Experiments were run in triplicate tests with four replicates in each 
test.   
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3.3.7 Confocal microscopy study with fluorescent viability dyes   
Three fluorescent viability dyes were used with confocal microscopy (Carl Zeiss LSM) to 
visualize live, dead, and apoptotic cells. The three dyes were: calcein AM, EthD-1, and 
annexin V. Calcein AM produces an intense green fluorescence in live cells after reaction 
with intracellular enzymes;
27
 EthD-1 binds to the nuclei of dead and dying cells and forms 
bright red fluorescence in the cells;
27
 annexin V stains the phosphatidylserine (PS) of 
apoptotic cells and dead cells.
28
 The natural color of annexin V fluorescence is red. However, 
in order to distinguish it from EthD-1 (which was also red), we set the confocal software to 
present annexin V as yellow. 
One ml of culture medium containing 4×10
5
 cells was transferred into collagen coated 
glass bottom culture Petri dishes and grown to confluence at 37 °C with 5% CO2 for 2 days. 
The cultures were then exposed to various treatments. After treatment, the cells were 
incubated with fresh culture medium at 37 °C with 5% CO2 for 2 h. After the incubation, the 
cells were stained with Annexin V (10 µl in 500 µl buffer), calcein AM (2 µM), and EthD-1 
(4 µM) for 20 min at 37 °C. Following staining, the fluorescence of the three dyes was 
visualized with an Axiovert 100 microscope with a Zeiss confocal laser scanning microscope 
(CLSM) 510 system. The excitation/emission wavelengths for calcein AM, EthD-1, and 
annexin V, were 495/515 nm, 528/617nm, and 650/665 nm, respectively. The experiments 
were performed with at least three replicates. 
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3.3.8 Statistical analysis  
The combined effects of UV radiation and BAK on HCEC in each treatment were 
evaluated by applying the statistical method reported by Ince et al.
29
 The method was based 
on testing the null hypothesis of “additive effect” at 95% confidence level. Specifically, the 
interaction of UV and BAK was assessed by comparing the observed combined toxicity with 
the value of the null hypothesis, defined as ‘‘the sum of the toxic effects of each agent given 
alone’’. The combined effects were called ‘‘additive’’, or ‘‘synergistic’’ according to the 
statistical significance and the sign of the difference between the calculated hypothesized 
value and the observed value.  
The calculation of the hypothesized values on metabolic activity (MAH) and cell viability 
(PCLH) was based on the following two equations.   
H0 Metabolic Activity:  MAH(UV + BAK)i = (MAUV) * (MABAK)i/100           (1) 
H0 Cell Viability:  PLCH(UV + BAK)i = (PLCUV) * (PLCBAK)i/100                  (2) 
In the equations, (UV + BAK)i was the combination of UV and BAK at i concentration; 
(MAUV) and (MABAK)i were the metabolic activity values (as % of control) for UV alone and 
BAK alone at i concentration. (PLCUV) and (PLCBAK)i were the percentages of live cells (as 
% of control) for UV alone and BAK alone at i concentration.  
One-way ANOVA was used in the data analysis of this study. The Bonferroni post hoc 
test was performed for the results of the PrestoBlue assay. The Games-Howell post hoc test 
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was used to analyze the cell counts in the confocal images because of the unequal variance of 
the data. The criterion for statistical significance was set to be p < 0.05.  
3.4 Results 
3.4.1 Metabolic activity 
The metabolic activity of HCEC after exposure to different treatments was measured with 
PrestoBlue. The results are shown in Figures 3-2, 3-3 and 3-4. The type of interaction 
between UV and BAK in each treatment was evaluated by applying a statistical analysis 
reported by Ince et al.29 The results are shown in Tables 3-1, 3-2 and 3-3. Figure 3-2 and 
Table 3-1 demonstrate the toxic effect of UV only, BAK only and UV plus BAK 
simultaneously. BAK alone reduced the cell metabolic activity of HCEC in a dose- and time- 
dependent manner. UV alone showed little cell toxicity and was not significantly different 
from the PBS control (p ≥ 0.561). However, when the cultures were exposed to UV plus 
BAK simultaneously, the toxicity of the treatments was significantly enhanced. Synergistic 
effects were observed in the followings: UV plus BAK 0.001% at 1 h, 2 h, 4 h and 8 h; UV 
plus BAK 0.002% and 0.003% at all the time points; and UV plus BAK 0.004% at 0 h and 2 
h. Additive effects were determined for all the rest of combinations tested (Table 3-1). 
Similar results were observed in the other two exposure orders: UV 1
st
 + BAK 2
nd
, and BAK 
1
st
 + UV 2
nd 
(Figures 3-3 and 3-4, Tables 3-2 and 3-3).  
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Figure 3-2. Cell metabolic activity measured with PrestoBlue_ UV and BAK simultaneously. 
The treatment of UV + BAK was carried out by exposing the cultures to UV and BAK 
simultaneously. The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 
min. Cell metabolic activity of HCEC was measured at various time points after exposure (0 
h, 1 h, 2 h, 4 h, and 8 h). The results are presented in percentage of cell metabolic activity 
compared to the PBS control. Error Bars: ± SD. * represents: significantly different from the 
PBS control (p < 0.05). The results are based on the average of three experiments with four 
samples in each experiment.  
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Figure 3-3. Cell metabolic activity measured with PrestoBlue_ UV 1st and BAK 2nd. 
The treatment of UV + BAK was carried out by exposing the cultures to UV 1
st
 and BAK 
2
nd
. The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. Cell 
metabolic activity of HCEC was measured at various time points after exposure (0 h, 1 h, 2 h, 
4 h, and 8 h). The results are presented in percentage of cell metabolic activity compared to 
the PBS control. Error Bars: ± SD. * represents: significantly different from the PBS control 
(p < 0.05). The results are based on the average of three experiments with four samples in 
each experiment.  
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Figure 3-4. Cell metabolic activity measured with PrestoBlue_ BAK 1st and UV 2nd. 
The treatment of UV + BAK was carried out by exposing the cultures to BAK 1
st
 and UV 
2
nd
. The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. Cell 
metabolic activity of HCEC was measured at various time points after exposure (0 h, 1 h, 2 h, 
4 h, and 8 h). The results are presented in percentage of cell metabolic activity compared to 
the PBS control. Error Bars: ± SD. * represents: significantly different from the PBS control 
(p < 0.05). The results are based on the average of three experiments with four samples in 
each experiment.  
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Table 3-1. Observed and calculated combined effects of UV and BAK in PrestoBlue assay --- simultaneous exposure 
BAK 
Concentration 
UV Dose  
( J/cm²) 
Test 
Time Point 
Observed Metabolic Activity 
vs. Control (MAobs) 
Calculated Metabolic Activity 
vs. Control (MAcal) 
Difference 
(MAobs- MAcal) 
Significance 
(p<0.05) 
Interactive 
Effect 
mean SD mean SD 
0.001% 0.1719 0 h 68.40 7.32 73.09 6.55 -4.69 No additive 
 0.1719 1 h 47.71 10.50 68.06 9.68 -20.35 Yes synergistic 
 0.1719 2 h 34.70 7.72 59.47 10.54 -24.77 Yes synergistic 
 0.1719 4 h 30.09 6.45 52.76 6.86 -22.67 Yes synergistic 
 0.1719 8 h 18.35 6.78 38.21 11.68 -19.86 Yes synergistic 
0.002% 0.1719 0 h 48.47 5.59 59.04 4.65 -10.57 Yes synergistic 
 0.1719 1 h 31.38 4.95 42.45 4.14 -11.07 Yes synergistic 
 0.1719 2 h 25.71 5.11 36.19 3.64 -10.48 Yes synergistic 
 0.1719 4 h 17.34 2.33 32.83 3.08 -15.49 Yes synergistic 
 0.1719 8 h 3.24 1.54 18.83 3.62 -15.59 Yes synergistic 
0.003% 0.1719 0 h 24.78 5.32 48.16 4.30 -23.38 Yes synergistic 
 0.1719 1 h 9.46 4.74 21.99 1.94 -12.53 Yes synergistic 
 0.1719 2 h 4.47 2.56 13.71 2.03 -9.24 Yes synergistic 
 0.1719 4 h 1.60 1.26 7.86 1.76 -6.26 Yes synergistic 
 0.1719 8 h 0.40 0.20 1.28 0.17 -0.88 Yes synergistic 
0.004% 0.1719 0 h 4.95 1.81 12.77 3.65 -7.82 Yes synergistic 
 0.1719 1 h 1.56 0.60 3.47 1.88 -1.91 No additive 
 0.1719 2 h 0.71 0.29 1.73 0.55 -1.02 Yes synergistic 
 0.1719 4 h 0.26 0.25 0.5 0.24 -0.24 No additive 
 0.1719 8 h 0.16 0.27 0.38 0.24 -0.22 No additive 
0.005% 0.1719 0 h 1.69 0.29 2.06 0.18 -0.37 No additive 
 0.1719 1 h 0.78 0.64 1.03 0.48 -0.25 No additive 
 0.1719 2 h 0.57 0.18 1.1 0.38 -0.53 No additive 
 0.1719 4 h 0.12 0.05 0.58 0.45 -0.46 No additive 
 0.1719 8 h 0.33 0.27 0.59 0.18 -0.26 No additive 
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Table 3-2. Observed and calculated combined effects of UV and BAK in PrestoBlue assay --- UV 1st and BAK 2nd 
BAK 
Concentratio
n 
UV Dose  
( J/cm²) 
Test 
Time Point 
Observed Metabolic Activity 
vs. Control (MAobs) 
Calculated Metabolic Activity 
vs. Control  (MAcal) 
Difference 
(MAobs- MAcal) 
Significance 
(p<0.05) 
Interactive 
Effect 
mean SD mean SD 
0.001% 0.1719 0 h 62.66 6.51 74.41 7.90 -11.75 No additive 
 0.1719 1 h 50.94 6.06 67.89 6.94 -16.95 Yes synergistic 
 0.1719 2 h 40.67 4.15 58.63 6.50 -17.96 Yes synergistic 
 0.1719 4 h 36.13 3.41 57.27 4.54 -21.14 Yes synergistic 
 0.1719 8 h 20.18 2.83 40.93 3.73 -20.75 Yes synergistic 
0.002% 0.1719 0 h 46.54 1.32 63.86 6.26 -17.32 Yes synergistic 
 0.1719 1 h 32.59 1.50 49.50 5.43 -16.91 Yes synergistic 
 0.1719 2 h 25.35 1.39 43.83 4.65 -18.48 Yes synergistic 
 0.1719 4 h 19.36 1.89 39.92 3.16 -20.56 Yes synergistic 
 0.1719 8 h 9.29 1.83 25.2 4.10 -15.91 Yes synergistic 
0.003% 0.1719 0 h 11.94 4.09 40.19 3.98 -28.25 Yes synergistic 
 0.1719 1 h 5.08 2.37 19.48 3.00 -14.40 Yes synergistic 
 0.1719 2 h 2.65 1.21 12.23 4.20 -9.58 Yes synergistic 
 0.1719 4 h 1.36 1.24 7.98 4.00 -6.62 Yes synergistic 
 0.1719 8 h 0.46 0.65 3.86 1.62 -3.40 Yes synergistic 
0.004% 0.1719 0 h 1.77 1.62 16.39 7.02 -14.62 Yes synergistic 
 0.1719 1 h 0.00 0.66 5.48 3.49 -5.48 Yes synergistic 
 0.1719 2 h 0.04 0.36 2.14 1.00 -2.10 Yes synergistic 
 0.1719 4 h 0.22 0.11 0.81 1.22 -0.59 No additive 
 0.1719 8 h 0.03 0.28 0.14 0.38 -0.11 No additive 
0.005% 0.1719 0 h 0.37 0.12 1.39 2.12 -1.02 No additive 
 0.1719 1 h 0.47 0.46 0.02 -0.68 0.45 No additive 
 0.1719 2 h 0.00 0.11 0.42 0.33 -0.42 No additive 
 0.1719 4 h 0.07 0.07 0.08 0.21 -0.01 No additive 
 0.1719 8 h 0.25 0.24 0.14 0.29 0.11 No additive 
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Table 3-3. Observed and calculated combined effects of UV and BAK in PrestoBlue assay --- BAK 1st and UV 2nd 
BAK 
Concentration 
UV Dose  
( J/cm²) 
Test 
Time Point 
Observed Metabolic Activity 
vs. Control (MAobs) 
Calculated Metabolic Activity 
vs. Control (MAcal) 
Difference 
(MAobs- MAcal) 
Significance 
(p<0.05) 
Interactive 
Effect 
mean SD mean SD 
0.001% 0.1719 0 h 63.75 9.88 71.34 6.44 -7.59 No additive 
 0.1719 1 h 56.71 5.86 69.53 5.83 -12.82 Yes synergistic 
 0.1719 2 h 54.38 7.20 73.57 6.25 -19.19 Yes synergistic 
 0.1719 4 h 46.20 6.37 60.89 6.79 -14.69 Yes synergistic 
 0.1719 8 h 23.19 1.98 30.99 5.39 -7.80 Yes synergistic 
0.002% 0.1719 0 h 51.19 4.49 63.52 5.28 -12.33 Yes synergistic 
 0.1719 1 h 46.09 3.64 56.68 5.30 -10.59 Yes synergistic 
 0.1719 2 h 38.30 7.38 56.11 9.43 -17.81 Yes synergistic 
 0.1719 4 h 31.11 6.51 44.85 6.17 -13.74 Yes synergistic 
 
0.1719 8 h 13.18 2.63 20.77 3.51 -7.59 Yes synergistic 
0.003% 0.1719 0 h 17.91 3.35 54.17 5.68 -36.26 Yes synergistic 
 0.1719 1 h 13.19 1.96 28.54 3.61 -15.35 Yes synergistic 
 0.1719 2 h 10.73 1.70 24.24 4.01 -13.51 Yes synergistic 
 0.1719 4 h 5.12 2.05 9.91 2.11 -4.79 Yes synergistic 
 0.1719 8 h 1.60 0.74 2.09 0.83 -0.49 No additive 
0.004% 0.1719 0 h 4.94 2.64 10.35 1.49 -5.41 Yes synergistic 
 0.1719 1 h 1.37 1.07 0.22 0.55 1.15 No additive 
 0.1719 2 h 0.70 0.94 2.50 0.52 -1.80 Yes synergistic 
 0.1719 4 h 1.12 0.67 0.95 0.24 0.17 No additive 
 0.1719 8 h 0.29 0.03 0.42 0.16 -0.13 No additive 
0.005% 0.1719 0 h 0.35 0.29 0.98 0.53 -0.63 No additive 
 0.1719 1 h 0.20 0.15 0.50 0.28 -0.30 No additive 
 0.1719 2 h 0.58 0.31 1.00 0.28 -0.42 No additive 
 0.1719 4 h 0.81 0.31 1.03 0.31 -0.22 No additive 
 0.1719 8 h 0.05 0.09 0.14 0.10 -0.09 No additive 
8
0
 
 81 
 
3.4.2 Confocal microscopy study with fluorescent viability dyes   
Cell viability of the cultures after various treatments was assessed using confocal 
microscopy with fluorescent viability dyes. The toxicity of treatments was illustrated by the 
distribution of live, dead and apoptotic cells in the cultures. Live healthy cells only stained 
with calcein AM (green); dead and necrotic cells were EthD-1 (red) - positive; apoptotic cells 
stained with both annexin V (yellow) and calcein AM (green). Figures 3-5 ~ 3-7 are 
representative confocal micrographs showing effects of the different treatments in various 
exposure orders. Similar results were observed in all the three exposure orders. BAK alone 
demonstrated a dose-dependent cell toxicity: the lowest concentration (0.001%) caused little 
cell death, while higher concentrations (0.004% and 0.005%) caused significant cell death 
(read) with obvious cell loss. UV alone had little effect on HCEC, showing similar cell 
viability compared to the PBS control. However, when combined with BAK, UV enhanced 
the toxicity of BAK, and together they caused significantly more cell death than BAK alone.  
The number of live, dead, and apoptotic cells in each culture were counted and the 
percentage of live cells in each treatment was shown in Figure 3-8. The combination of UV 
and BAK caused significantly more cell death than UV and BAK individually (p < 0.05). 
The type of interaction existing between these two agents was evaluated and shown in Table 
3-4. In all the three exposure orders, synergistic effects were found between UV and BAK 
0.002%, 0.003%, and 0.004%; whereas, additive effects were shown between UV and BAK 
0.001% and 0.005%.  
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Figure 3-5. Representative confocal laser scanning micrographs of HCEC at 2 h after exposure_ 
UV and BAK simultaneously. 
The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. The treatment 
of UV + BAK was carried out by exposing the cultures to UV and BAK simultaneously. The 
cell viability of HCEC after treatment is illustrated by the distributions of live, dead, and 
apoptotic cells in the culture. Live cells are calcein AM (green)-positive, annexin V (yellow)-
negative, and EthD-1(red)-negative; dead cells are EthD-1 (red)-positive; apoptotic cells are 
annexin V (yellow)-positive and EthD-1 (red)-negative. All the micrographs were taken at 
the same magniﬁcation.  
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Figure 3-6. Representative confocal laser scanning micrographs of HCEC at 2 h after exposure_ 
UV 1st and BAK 2nd. 
The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. The treatment 
of UV + BAK was carried out by exposing the cultures to UV 1
st
 and BAK 2
nd 
. The cell 
viability of HCEC after treatment is illustrated by the distributions of live, dead, and 
apoptotic cells in the culture. Live cells are calcein AM (green)-positive, annexin V (yellow)-
negative, and EthD-1(red)-negative; dead cells are EthD-1 (red)-positive; apoptotic cells are 
annexin V (yellow)-positive and EthD-1 (red)-negative. All the micrographs were taken at 
the same magniﬁcation. 
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Figure 3-7. Representative confocal laser scanning micrographs of HCEC at 2 h after exposure_ 
BAK 1st and UV 2nd. 
The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. The treatment 
of UV + BAK was carried out by exposing the cultures to BAK 1
st
 and UV 2
nd 
. The cell 
viability of HCEC after treatment is illustrated by the distributions of live, dead, and 
apoptotic cells in the culture. Live cells are calcein AM (green)-positive, annexin V (yellow)-
negative, and EthD-1(red)-negative; dead cells are EthD-1 (red)-positive; apoptotic cells are 
annexin V (yellow)-positive and EthD-1 (red)-negative. All the micrographs were taken at 
the same magniﬁcation.  
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Figure 3-8. Percentage of live cells in the confocal laser scanning micrographs. 
The UV dose used was 0.1719 J/cm², and the BAK exposure time was 10 min. * represents: 
significantly different from the PBS control (p < 0.05). The results are based on the average 
of at least three experiments.  
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Table 3-4. Observed and calculated combined effects of UV and BAK in confocal microscopy study 
Exposure Order 
UV Dose 
( J/cm²) 
BAK 
Concentration 
Observed Percentage 
of Live Cells vs. Control        
(PLCobs) 
Calculated Percentage 
of Live Cells vs. Control                
(PLCcal) 
Difference 
(PLCobs- PLCcal) 
Significance 
(p<0.05) 
Interactive 
Effect 
mean SD mean SD 
UV and BAK 
simultaneously 
0.1719 0.001% 96.39 1.46 97.81 1.34 -1.42 No additive 
 0.1719 0.002% 77.45 7.20 91.93 2.90 -14.48 Yes synergistic 
 0.1719 0.003% 44.21 7.92 73.16 5.94 -28.95 Yes synergistic 
 0.1719 0.004% 6.70 7.54 26.56 2.96 -19.86 Yes synergistic 
 0.1719 0.005% 0.80 1.12 4.06 4.48 -3.26 No additive 
UV 1
st
 and BAK 2
nd
 0.1719 0.001% 88.59 2.53 93.19 3.03 -4.60 No additive 
 0.1719 0.002% 76.47 7.44 85.27 5.72 -8.80 Yes synergistic 
 0.1719 0.003% 25.78 7.91 62.41 9.29 -36.63 Yes synergistic 
 0.1719 0.004% 1.48 1.30 36.44 7.07 -34.96 Yes synergistic 
 0.1719 0.005% 0.00 0.00 0.86 1.49 -0.86 No additive 
BAK 1
st
 and UV 2
nd
 0.1719 0.001% 92.13 1.40 96.49 2.95 -4.36 No additive 
 0.1719 0.002% 77.42 4.56 94.34 2.37 -16.92 Yes synergistic 
 0.1719 0.003% 38.43 7.22 71.64 3.32 -33.21 Yes synergistic 
 0.1719 0.004% 10.56 9.27 38.39 10.40 -27.83 Yes synergistic 
 0.1719 0.005% 1.91 0.62 5.87 6.27 -3.96 No additive 
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3.4.3 Photoreactivity test 
A photoreactivity test was conducted to see whether UV radiation acts on BAK and 
increases or decreases the cell toxicity of BAK. The cultures exposed to untreated and UV-
treated BAK were measured for metabolic activity with PrestoBlue. The result is shown in 
Figure 3-9. In most of the concentrations at most of the time points, there was no significant 
difference in the cell toxicity between untreated BAK and UV-treated BAK. Whereas, UV-
treated BAK showed slightly lower cell toxicity compared to untreated BAK in the following 
concentrations and time points: 0.001% and 0.002% at 8 h; 0.003% at 0 h, 1 h and 4 h; and 
0.004% at 0 h and 1 h. The differences were small but statistically significant (p = 0.001 ~ 
0.016).       
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Figure 3-9. Comparison of untreated BAK and UV-treated BAK using PrestoBlue.  
The UV dose used to treat BAK solutions was 0.1719 J/cm². The effect of untreated and UV-
treated BAK solutions on the metabolic activity of HCEC was measured at various time 
points after exposure (0 h, 1 h, 2 h, 4 h, and 8 h). The results are presented in percentage of 
cell metabolic activity vs. PBS control. Error Bars: ± SD. * represents: significantly different 
from each other (p = 0.001 ~ 0.016). The results are based on the average of three 
experiments.    
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3.5 Discussion 
3.5.1 Background  
In daily life, human eyes are exposed to sunlight and various chemicals, such as personal 
hygiene products, ocular and systemic mediations, air pollutants, make-up, and skin care 
products. The ocular toxicity of these potential toxic agents is dependent on the dose and 
time of exposure. During ocular safety testing the effect of each individual chemical is 
assessed and the additive or synergistic effects are measured if the chemicals are added into 
product formulations. As noted in the introduction, an additive effect occurs when the 
combined effect is equal to the sum of the individual effect; while a synergistic effect takes 
place when the combined effect is greater than the sum of the effects of each agent given 
alone. In most cases, FDA approved products are safe (below toxicity thresholds) when used 
as directed. However, product safety testing does not always include toxic reactions due to 
non-compliance to the product use procedures, contra-indications with other drugs used, or 
additional exposure to environmental conditions (such as UV exposure). It is important to 
assess the potential impact of co-exposures to multiple toxic agents, as the co-exposure may 
enhance individual toxicity and produce an effect that exceeds the threshold level. The eye is 
exposed to solar UV radiation in a daily basis; as yet, little attention has been paid to the 
combined effects of UV radiation and other toxic agents on the eye.    
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3.5.2 Combined toxicity of UV radiation and BAK 
The present study investigated the combined toxicity of UV radiation and BAK on 
cultured HCEC. Our results indicated that synergistic effects can occur between a low dose 
of UV radiation (0.1719 J/cm
2
) and low concentrations of BAK (0.001%-0.004%). This is 
the first demonstration of the synergistic effect between UV and BAK in human cells. In 
addition, additive effects between UV and BAK were also observed in our study. This is in 
accordance with one previous experiment, in which Withrow et al. described that the 
combined effect of UVA and BAK on mouse lymphoma cells appeared to be additive.21  
3.5.3 Comparison of the results of PrestoBlue assay and confocal microscopy 
In our study, the combined toxicity was evaluated with two different in vitro assays. In 
the PrestoBlue assay, the synergistic effects were mainly shown between UV and the lower 
concentrations of BAK: 0.001%, 0.002% and 0.003%. BAK 0.004% and 0.005% 
demonstrated extremely high individual toxic effects and reduced cell metabolic activity to 
no more than 5%; hence, it was difficult to observe any synergistic effects in these two 
concentrations. All three exposure orders (UV and BAK simultaneously, UV 1
st
 and BAK 
2
nd
, BAK 1
st
 and UV 2
nd
) showed similar results, suggesting that the synergistic effects were 
independent of the exposure order. This independence was confirmed in the second assay: 
confocal microscopy with cell viability dyes. However, in the second assay, the synergistic 
effects were observed between UV and the higher concentrations of BAK 0.002%, 0.003% 
and 0.004%. One possible reason for this difference between two assays is that the 
PrestoBlue assay is more sensitive than the confocal microscopy. The PrestoBlue assay 
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measures cell metabolic activity;30 whereas the confocal microscopy demonstrates cell 
viability (live, dead and apoptotic).27,28,31 Low levels of toxicity decrease cell metabolic 
activity but do not cause cell death or apoptosis.  
3.5.4 Photoreactivity test 
A photoreactivity test was conducted to further investigate whether UV radiation acts on 
BAK and increases or decreases BAK toxicity. The result showed that, in most of the 
concentrations and most time points, the cell toxicities of UV-treated BAK and untreated 
BAK were similar. This finding, in conjunction with the results of the other two experiments 
in this study, suggested that very little interaction occurred between UV and BAK. This is 
not surprising, because the absorption of UV radiation by BAK is essential for any 
interaction to occur. BAK does not absorb at wavelengths > 290 nm,21,32 while, the UV 
radiation source used in our study mainly emitted UVA and UVB (280 – 400 nm). As a 
result, the absorption of UV radiation by BAK was likely small. Nevertheless, in a few 
concentrations at some specific time points, UV-treated BAK showed slightly less cell 
toxicity compared to untreated BAK. The differences were small but statistically significant. 
It is likely that a photochemical reaction occurred along with the small absorption of UV 
radiation, and turned BAK into a less toxic substance.  
3.5.5 Potential mechanism  
Our study revealed that UV radiation and BAK can have a synergistic effect on HCEC. 
However, the mechanism for this effect is not clear. One possibility is a photosensitization 
 92 
 
mechanism, as many chemicals are shown to have certain or potential photosensitizing 
effects on the eye.33-36 These chemicals are photoreactive and can cause damage to the eye on 
the presence of light. Nevertheless, the following points would argue against this mechanism. 
First, if the photosensitization occurred, exposing the cells to BAK and UV simultaneously 
would generate stronger toxic effect than the exposures conducted in sequence. However, 
similar synergistic effects were observed in all the three different exposure orders. Also, in 
the photoreactivity test, UV-treated BAK had similar or slightly lower cell toxicity than 
untreated BAK, suggesting that UV reduced the toxicity of BAK instead of increasing it. 
Moreover, the absorption of UV radiation by BAK is essential for photosensitization to 
occur;37 but as discussed above, the absorption was likely inconsequential. Thus, this 
mechanism is not well supported.    
It is well known that BAK induces cell death through membrane destruction.38,39 Also, 
BAK has been shown to cause DNA damage and cell apoptosis via the introduction of 
reactive oxygen species (ROS).40,41 UV radiation is associated with photochemical damage to 
ocular tissues. UVB damages DNA directly, leading to the formation of pyrimidine dimers;42 
while UVA indirectly damages DNA through the production of oxygen radical species.42 
Experimental evidence also showed that UV radiation can decrease mitochondrial function43 
and induce apoptosis.44 It is possible that UV and BAK enhanced each other’s toxic effect 
through the combination of their different mechanisms. Further study is required to 
investigate the mechanism involved, as well as to confirm the significance of the synergistic 
effect in vivo.  
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3.5.6 Conclusion  
In summary, our study indicates that co-exposure to UV radiation and BAK can cause 
synergistic and additive effects on human corneal epithelial cells. This finding highlights the 
importance of considering the combined ocular toxicity of solar radiation and BAK in the 
risk assessment of BAK-preserved ophthalmic solutions.  
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As noted in Chapter 3, UV (UVA and UVB)-irradiated BAK had similar or slightly lower 
cell toxicity than untreated BAK. Since BAK absorbs wavelengths < 290 nm, which falls 
mainly in UVC region, an appropriate dose of UVC radiation may be able to reduce the 
toxicity of BAK completely. The next chapter investigated whether the BAK toxicity on 
HCEC can be neutralized by UVC radiation. 
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4.1 Overview 
Purpose: To investigate the detoxification of benzalkonium chloride (BAK) by 
ultraviolet C (UVC) radiation.  
Methods: BAK solutions were irradiated with a germicidal UVC lamp at various doses. 
Human corneal epithelial cells (HCEC) were then exposed to the UVC-irradiated BAK 
solutions for 5 minutes. After exposure, the cultures were assessed for metabolic activity 
using PrestoBlue; cell viability using confocal microscopy with viability dyes; and 
membrane integrity using immunofluorescence staining for zonula occludens (ZO)-1. The 
antimicrobial efficacy of UVC-irradiated BAK against Pseudomonas aeruginosa (P. 
aeruginosa) was also assessed. Phosphate buffered saline (PBS) was used as a negative 
control.  
Results: BAK toxicity on cell metabolic activity was reduced by UVC radiation in a 
dose-dependent manner. When the solution depth of BAK was 1.7 millimeter, the UVC 
doses needed to completely neutralize the toxicity of BAK 0.005% and 0.01% were 2.093 
J/cm
2
 and 8.374 J/cm
2
, respectively. Cell viability of the cultures treated with UVC-
neutralized BAK was similar to the cultures treated with PBS. After exposure to PBS and 
UVC-neutralized BAK, the tight junction proteins ZO-1 were well maintained. In contrast, 
the expression of ZO-1 was greatly disturbed by untreated BAK. The antimicrobial effect of 
BAK against P. aeruginosa was reduced after UVC irradiation. 
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Conclusions: The cell toxicity of BAK can be neutralized by UVC irradiation. This 
finding provides a unique way of detoxifying BAK, and may be of great value in utilizing the 
antimicrobial efficacy of BAK while minimizing its potential hazards to human health and 
the environment. 
4.2 Introduction 
Benzalkonium chloride (BAK) is a group of quaternary ammonium compounds (QACs) 
that have an extremely wide range of applications, such as biocides, disinfectants, food 
additives, as well as preservatives in pharmaceutical and cosmetic products. Benzalkonium is 
composed by a positively charged nitrogen atom linked to a long alkyl chain (ranging from 8 
to 18 carbon atoms) on one side, and a benzyl group on the other. The two last positions are 
occupied by methyl groups (Figure 4-1).1 The key mechanism of BAK’s antimicrobial action 
is membrane destruction, which is effective against bacteria, enveloped viruses, and some 
fungi, yeasts and protozoa.2 Because of BAK’s efficiency, stability and low cost, it has 
become a major non-alcohol-based active ingredient used for hospitals, food processing 
plants, and domestic household biocides.3,4  
However, BAK has its limitations. Its toxicity has garnered much attention with 
widespread studies revealing its hazardous effects. It has been shown to cause allergic 
contact dermatitis,5 eye irritations,6 and ototoxicity in humans.7 It is also a suspected 
genotoxicant due to its ability in causing DNA changes in respiratory epithelial cells in vitro.8 
With regard to ecological risk, BAK is categorized as highly toxic to fish, very highly toxic 
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to aquatic invertebrates, and moderately toxic to birds on an acute basis.9 As a result, the 
potential hazards of BAK and its residues are causing human health and environmental 
concerns.  
 
 
 
Due to the extensive applications of BAK and the accumulating evidence on its toxicity, 
considerable effort has been put into the development of methods to minimize BAK’s 
toxicity. High molecular weight hyaluronan,10 sodium hyaluronate (SH),11 polyoxyethylene 
hydrogenated castor oil 40 (HCO-40) and polysorbate 80 (PS-80)12 are a few of the 
chemicals that have been reported to have some protective effects against the ocular toxicity 
of BAK in ophthalmic solutions. Very little is reported in the literature on ways to minimize 
the toxicity of BAK in other applications such as cleaners and disinfectants in the healthcare 
and food processing industries. Ultraviolet (UV) radiation, as opposed to the chemical 
disinfectants, uses a physical process to inactivate microorganisms and does not generate any 
hazardous residues.13 To the best of our knowledge, there is no report on the use of UVC 
radiation in mitigating the toxic effect of BAK.  
Figure 4-1. Molecular structure of benzalkonium 
chloride. 
From Wikimedia Commons, the free media repository. 
File:Benzalkonium Chloride Structure V.1.svg 
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The aim of this study was to investigate the detoxification of BAK using an in vitro 
toxicity model. For this purpose, BAK solutions were exposed to different doses of UVC 
radiation. Then the toxic effect of the UVC-irradiated BAK on HCEC was assessed with in 
vitro assays that measure cell metabolic activity, cell viability and tight junction proteins. 
The antimicrobial efficacy of UVC-neutralized BAK against Pseudomonas aeruginosa (P. 
aeruginosa) was also assessed.  
4.3 Materials and Methods 
4.3.1 Materials 
Human corneal epithelial cells (HCEC) were obtained from RIKEN BioResource Center, 
Tsukuba, Japan (#RCB 2280). It is a SV40-transformed human corneal epithelial cell line 
that has good growth characteristics, develops good tight junctions, and is free of infectious 
virus particles.14-16 DMEM/F-12 Ham Medium, fetal bovine serum, penicillin/streptomycin, 
Tryple Express, PrestoBlue, calcein AM, ethidium homodimer-1 (EthD-1), annexin V-Alexa 
Fluor 647 conjugate (annexin V), ZO-1 mouse monoclonal antibody, and Alexa Fluor 488 
Goat Anti-Mouse IgG (H+L) antibody were all purchased from Life Technologies Inc. 
(Burlington, ON). Cell culture plates (24-well plates) were obtained from BD Falcon 
(Franklin Lakes, NJ). Collagen coated glass bottom culture Petri dishes were from MatTek 
Corp (Ashland, MA). Polystyrene and polypropylene wells were purchased from VWR 
(Mississauga, ON). 
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P. aeruginosa was obtained from ATCC Rockville, MD, USA (ATCC 9027). Tryptic 
Soy Agar (TSA) was produced by Fisher Scientific (Pittsburgh, PA). Blood agar was from 
VWR (Mississauga, ON).  
Benzalkonium chloride (BAK), 100% methanol, and Dey-Engley Neutralizing Broth 
were purchased from Sigma-Aldrich (St. Louis, MO). Phosphate buffered saline (PBS) was 
obtained from Lonza (Walkersville, MD).   
4.3.2 Cell culture  
HCEC were grown in DMEM/F-12 Ham Medium with 10% fetal bovine serum and 1% 
penicillin/streptomycin in a humidified environment at 37 °C with 5% CO2. These cultures 
were maintained with weekly subculture using Tryple Express and fed every 2 to 3 days. To 
ensure consistency among experiments, the monolayers of HCEC were prepared with 
cultures that were less than 10 passages. 
4.3.3 UV exposure  
UV exposure was produced by one commercial germicidal UVC lamp (Light Spectrum 
Enterprises, Inc., Philadelphia, PA) in a custom designed UV irradiation unit at room 
temperature (22 °C). Before irradiation, the spectrum and irradiance of UVC source was 
measured with an USB 2000+ fiber optic spectrometer (Ocean Optics, Inc. Dunedin, FL). 
The result is shown in Figure 4-2. The central wavelength was 253.7 nanometers (nm) and 
the calculated irradiance level was 2.9075 watts per square meter (W/m
2
).  
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BAK solutions (0.005% and 0.01% in PBS) were transferred into sterile, flat bottom 
wells and irradiated for 10 min, 30 min, 1 h, 2 h, 4 h, and 8 h. The corresponding doses were 
0.175, 0.523, 1.047, 2.093, 4.187 and 8.374 J/cm
2
. The wells were covered with quartz to 
prevent evaporation during UV irradiation. The amount of BAK solution in each well was 
measured accordingly to achieve a specified solution depth. The solution depths used in our 
study were relatively thin in order to allow maximum interaction between UV radiation and 
BAK.   
To assess how solution depth and well material affects the neutralization of BAK by 
UVC, two solution depths (1.7 mm and 3.4 mm) and two well materials (polystyrene and 
polypropylene) were tested. The treated BAK solutions were then tested on cells using 
PrestoBlue. To assess whether BAK toxicity changes depending on the time of assessment 
after UV exposure, each BAK solution was divided into two aliquots. The first aliquot was 
tested for its toxicity immediately (at 0 h) after UV exposure; the second aliquot was placed 
in the dark for 24 h after UV exposure, and then tested for its toxicity.     
 
 102 
 
 
Figure 4-2. Spectrum of the UVC lamp measured with an USB 2000+ fiber optic spectrometer. 
The UVC source used in our experiments was one commercial germicidal UVC lamp. The 
central wavelength was 253.7 nm; the irradiance was 2.9075 W/m². 
 
4.3.4 PrestoBlue assay  
One milliliter (ml) of cell suspension containing 10
5
 cells was seeded in 24-well plates 
and grown to approximately 75% to 80% confluent at 37 °C with 5% CO2. The cells were 
then exposed to test solutions for 5 min. After exposure, the test solutions were removed and 
the cultures were rinsed with 1ml of PBS. One ml of 10% PrestoBlue reagent prepared in 
medium without serum and phenol red was then added to each well and the cultures were 
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incubated at 37 °C for 1 h. After incubation, the change in the fluorescence of PrestoBlue 
reagent (resazurin to resorufin) was measured using a SpectraMax fluorescence multi-well 
plate reader (Molecular Devices, Sunnyvale, CA) with the excitation/emission wavelengths 
set at 560/590 nm.  
4.3.5 Confocal microscopy study with fluorescent viability dyes   
Three fluorescent viability dyes were used with confocal microscopy (Carl Zeiss LSM) to 
visualize live, dead, and apoptotic cells. They were calcein AM, EthD-1, and annexin V. 
Calcein AM produces an intense green fluorescence in live cells after reaction with 
intracellular enzymes; EthD-1 binds to the nuclei of dead and dying cells; annexin V stains 
the phosphatidylserine (PS) of apoptotic cells and dead cells.  
One ml of culture medium containing 4×10
5
 cells was transferred into collagen coated 
glass bottom culture Petri dishes and grown to confluence at 37 °C with 5% CO2 for 2 days. 
The cultures were then exposed to test solution for 5 min. After exposure, the test solutions 
were removed, and the cultures were rinsed with 1ml of PBS. The cells were then stained 
with Annexin V [10 microliter (µl) in 500 µl buffer], calcein AM [2 micromolar (µM)], and 
EthD-1 (4 µM) for 20 min at 37 °C. After staining, the fluorescence of the three dyes was 
visualized with an Axiovert 100 microscope with a Zeiss confocal laser scanning microscope 
(CLSM) 510 system. The excitation/emission wavelengths for calcein AM, EthD-1, and 
annexin V were 495/515 nm, 528/617nm, and 650/665 nm, respectively.  
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4.3.6 ZO-1 and Hoechst fluorescence staining  
The distribution of tight junction protein zonula occludens-1 (ZO-1) was assessed by 
immunofluorescence staining with confocal scanning laser microscopy. ZO-1 mouse 
monoclonal antibody and Alexa Fluor® 488 Goat Anti-Mouse IgG (H+L) antibody were 
used as primary and secondary antibody, respectively. Hoechst 33342 was used for nuclear 
counterstaining. 
One ml of culture medium containing 4×10
5
 cells was transferred into collagen coated 
glass bottom culture Petri dishes and grown to confluence at 37 °C with 5% CO2 for 2 days. 
The cultures were then exposed to test solution for 5 min. After exposure, the test solutions 
were removed, and the cultures were rinsed with 1ml of PBS. The cultures were then fixed 
with 100% methanol for 20 min at -20°C and rinsed 4 times with PBS at room temperature 
(RT). Nonspecific antibody binding was blocked with 2% bovine serum albumin (BSA) in 
PBS (1 h, RT). For ZO-1 staining, the monolayers were first incubated with primary ZO-1 
antibody (5 µg/ml in 2% BSA, 1 h, 37°C) followed by 4 rinses with PBS, and then incubated 
with secondary antibody Alexa Fluor® 488 Goat Anti-Mouse antibody (2µg/ml in 2% BSA, 
1h, 37°C) and rinsed 4 times with PBS again. For nuclear counterstaining, the cultures were 
incubated with Hoechst 33342 (10 µg/ml in clear medium, 15 min, 37°C) and washed twice 
with PBS. After staining, the samples were examined using an Axiovert 100 microscope with 
a Zeiss confocal laser scanning microscope (CLSM) 510 system. The excitation/emission 
wavelengths for Alexa Fluor® 488 Goat Anti-Mouse antibody and Hoechst 33342 were 
495/520 nm and 355/460 nm, respectively.  
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4.3.7 Antimicrobial efficacy of BAK against P. aeruginosa  
Preparation of bacterial suspensions: P. aeruginosa was regrown from frozen stocks 
onto a flask containing blood agar at 37 ºC for 24 hours. The organism was harvested with 10 
ml of PBS, centrifuged for 5 min at 490 relative centrifugal force (RCF) to a pellet, and re-
suspended in PBS. A cell concentration of 1.0 x 10
8
 colony forming units (CFU) per ml was 
used. To ensure a good degree of reproducibility, a Den-1 spectrophotometer (Grant 
Instruments, Cambridge, UK) was used with an optical density (OD) of 0.3 being equivalent 
to a bacterial concentration of 1.0 x 10
8
 CFU/ml.  
Measurement of antibacterial activity of BAK: An aliquot of 0.03 ml of bacterial 
suspension (1.0 x 10
8
 CFU/ml) was added to each tube containing 3 ml of test solution. This 
produced a bacterial concentration of approximately 1.0 x 10
6
 CFU/ml. The tube was 
vortexed to mix well and left in room temperature for 5 min. After the 5 min exposure, 1 ml 
of the tube solution was added to 1 ml of Dey-Engley Neutralizing Broth (DEB), mixed well 
and incubated for 15 min for neutralization. A continuous series of decimal dilutions of the 
neutralized solution were made in PBS until the concentration of bacteria reached the level of 
1.0 CFU/ml. The viable count of bacteria in all the dilutions was assessed by preparation of 
triplicate plates of Tryptic Soy Agar (TSA). The plates were incubated at 37 °C for 72 h and 
then counted manually for CFU. 
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4.3.8 Statistical analysis  
The experiments were performed with four replicates. One-way ANOVA was used in the 
data analysis of this study. Pairwise multiple comparison procedures were performed using 
the Bonferroni post hoc test. The criterion of statistical significance was set to be p < 0.05. 
4.4 Results 
4.4.1 Metabolic activity  
The metabolic activity of HCEC after exposure to UVC-irradiated and untreated BAK 
was measured using PrestoBlue. The result is shown in Figure 4-3. This experiment was 
conducted with a solution depth of BAK set at 1.7 mm during UVC irradiation. The 
untreated BAK 0.005% and 0.01% reduced metabolic activity of HCEC to 20% and 0%, 
respectively, demonstrating significant cell toxicity after 5 min exposure. UVC irradiation 
lowered the toxicity of BAK in a dose-dependent manner. As the UVC dose increased, the 
toxicity of UVC-irradiated BAK decreased. The cultures treated by 2h UVC-irradiated BAK 
0.005% and 8 h UVC-irradiated BAK 0.01% showed similar metabolic activity compared to 
those treated with the PBS control (p = 1.000 and 0.806, respectively). This suggests that 
when the solution depth of BAK was 1.7 mm, complete neutralization of BAK toxicity was 
achieved within 2 hours of UVC radiation (2.093 J/cm
2
) for BAK 0.005% and within 8 hours 
of UVC radiation (8.374 J/cm
2
) for BAK 0.01%. Therefore, under this condition, we refer to 
the 2 hour UVC-irradiated BAK 0.005% and the 8 hour UVC-irradiated BAK 0.01% as 
UVC-neutralized BAK.  
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Figure 4-3. Effect of the test solutions on the metabolic activity of HCEC after 5 min exposure 
measured by PrestoBlue. 
The BAK solutions were positioned in polystyrene wells with a solution depth of 1.7 mm 
while exposed to UVC radiation. The toxicity of the solutions was evaluated right after UVC 
irradiation. The results are presented in percentage of cell metabolic activity compared to the 
PBS control. Error Bars: ± SD. * Indicates significantly different from untreated BAK 
0.005% (p = 0.001~ 0.006). ∆ Indicates significantly different from untreated BAK 0.01% (p 
= 0.001~ 0.017). #
 
Indicates not significantly different from the PBS control (p = 1.000 and 
0.806, respectively).  
  
 108 
 
To investigate the effect of solution depth of BAK, well material, and time of assessment 
on the UVC neutralization effect, two solution depths (1.7 mm and 3.4 mm), two well 
materials (polystyrene and polypropylene), and two assessment times (0 h and 24 h after 
UVC irradiation) were tested and compared in our study (Figure 4-4). When the solution 
depth of BAK increased from 1.7 mm to 3.4 mm, the cell toxicity of UVC-irradiated BAK 
0.01% increased significantly (p < 0.01), while the cell toxicity of UVC-irradiated BAK 
0.005% was not changed (p = 0.922) (Figure 4-4_Solution Depth). The results obtained with 
polystyrene wells and polypropylene wells were similar (Figure 4-4_Well Material, p ≥ 
0.712). Also, there was no significant difference between the cell toxicity tested at 0 h after 
UVC irradiation and that tested at 24 h after UVC irradiation (Figure 4-4_Measure Time, p ≥ 
0.761).  
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Figure 4-4. Toxicity of UVC-irradiated BAK under various UVC irradiation conditions and at 
different times of measurement. 
The toxicity of the test solutions on HCEC was assessed with the PrestoBlue assay. BAK 
0.005% and 0.01% were irradiated by UVC at two solution depths (1.7mm and 3.4 mm) with 
two well materials (polystyrene and  polypropylene), and the toxicity of UVC-irradiated 
BAK was measured at 0 h and 24 h after UV irradiation. PBS was used as a negative control. 
The results are presented in percentage of cell metabolic activity compared to the control. 
Error Bars: ± SD. * Indicates significantly different from each other (P < 0.001).  
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The following experiments were based on the result of metabolic activity shown in 
Figure 4-3. In these experiments, we further investigated the effect of UVC-neutralized BAK 
on cell viability and tight junctions of HCEC, as well as its antimicrobial activity against P. 
aeruginosa.  
4.4.2 Confocal microscopy study with fluorescent viability dyes   
Confocal microscopy with fluorescent viability dyes (calcein AM, EthD-1 and annexin 
V) illustrated the cell viability of cultures by showing the distribution of live, dead, and 
apoptotic cells in the cultures. Figure 4-5 shows the representative confocal laser scanning 
micrographs of HCEC after 5 min exposure to the test solutions. The culture treated by PBS 
control showed approximately 100% cell alive (green). The untreated BAK demonstrated 
significant cell toxicity in a dose-dependent manner, with the untreated BAK 0.01% causing 
100% cell death (red). The cells exposed to UVC-neutralized BAK 0.005% and 0.01% had 
similar cell viability to those exposed to PBS control, showing very few apoptotic cells 
(yellow) in the live cell (green) background.   
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Figure 4-5. Effect of the test solutions on the cell viability of HCEC after 5 min exposure 
assessed by confocal microscopy with viability dyes. 
Live cells are calcein AM (green)-positive, annexin V (yellow)-negative, and EthD-1(red)-
negative; dead cells are EthD-1 (red)-positive; apoptotic cells are annexin V (yellow)-
positive and EthD-1 (red)-negative. The yellow arrows indicate live cells; the red arrows 
show cells in apoptosis; the white arrows indicate dead cells. Bar = 50 µm. All the 
micrographs were taken at the same magniﬁcation. The UVC-neutralized BAK 0.005% and 
0.01% were irradiated by UVC for 2 h and 8 h, respectively. The corresponding UVC doses 
were 2.093 J/cm
2 
and 8.374 J/cm
2
.   
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4.4.3 ZO-1 and Hoechst fluorescence staining  
The effect of UVC-neutralized BAK on HCEC tight junctions was investigated by 
confocal microscopy with ZO-1 and Hoechst fluorescence staining. The distribution of tight 
junction proteins ZO-1 after 5 min exposure to the test solutions is shown in Figure 4-6. The 
culture exposed to PBS control showed intact cell junctions with regular distributions of ZO-
1 on the cell borders. However, the distribution of ZO-1 proteins was significantly disturbed 
by the untreated BAK 0.005%, and was almost completely destroyed by the untreated BAK 
0.01%. In contrast, the cultures treated by UVC-neutralized BAK exhibited a normal, 
continuous linear pattern of ZO-1 proteins along the cell-cell junctions, which was similar to 
the culture exposed to PBS control.  
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Figure 4-6. Effect of the test solutions on the distribution of tight junction proteins ZO-1 of 
HCEC after 5 min exposure. 
ZO-1 proteins were labeled with Alexa Fluor 488 (green); nuclei were stained with Hoechst 
33342 (blue). Bar = 50 µm. All the micrographs were taken at the same magniﬁcation. The 
UVC-neutralized BAK 0.005% and 0.01% were irradiated by UVC for 2 h and 8 h, 
respectively. The corresponding UVC doses were 2.093 J/cm
2 
and 8.374 J/cm
2
.  
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4.4.4 Antimicrobial efficacy against P. aeruginosa 
The antimicrobial efficacy of UVC-neutralized BAK and untreated BAK against P. 
aeruginosa is shown in Figure 4-7. In a 5-min disinfection time, the untreated BAK 0.005% 
and 0.01% killed all the P. aeruginosa. In contrast, UVC- neutralized BAK 0.005% and 
0.01% showed little antimicrobial efficacy with a great number of bacterial survivors. There 
was no significant difference in the number of bacterial survivors between UVC- neutralized 
BAK 0.005% and the PBS control (p = 1.000).    
 
Figure 4-7. Number of survivors of P. aeruginosa after 5 min exposure to the test solutions. 
Error Bars: ± SD. * Indicates significantly different from untreated BAK 0.005% and 0.01% 
(p < 0.001), but not significantly different from the PBS control (p = 1.000); # Indicates 
significantly different from the PBS control and untreated BAK 0.005% and 0.01% (p < 
0.001). The UVC-neutralized BAK 0.005% and 0.01% were irradiated by UVC for 2 h and 8 
h, respectively. The corresponding UVC doses were 2.093 J/cm
2 
and 8.374 J/cm
2
.  
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4.5 Discussion 
Benzalkonium chloride (BAK) is extensively used in different disinfectant formulations; 
however, it is highly toxic to humans and the environment.5-8,17 After being released to the 
environment, BAK residue is stable to microbial degradation, hydrolysis and direct 
photolysis by sunlight.18 Therefore, substantial effort has been put into minimizing the 
potential hazards of BAK and its residues.    
Considerable progress has been made in mitigating BAK toxicity in ophthalmic solutions. 
High molecular weight hyaluronan was found to significantly decrease oxidative stress, 
apoptosis and necrosis induced by BAK in human epithelial cells.10 Latanoprost and 
travoprost were reported to protect conjunctiva-derived epithelial cells against BAK toxicity 
in vitro.19 Polyoxyethylene hydrogenated castor oil 40 (HCO-40) and polysorbate 80 (PS-80) 
were shown to alleviate the corneal toxicity of BAK.12 Topical application of sodium 
hyaluronate (SH) was proposed to reduce ocular toxicity induced by BAK-preserved 
latanoprost.11  
Nevertheless, little research has been done on eliminating the toxic effect of BAK and its 
residues in other applications, such as disinfectants and cleaners in the health care and food 
processing industries. To the best of my knowledge, there is no report on utilizing UVC 
radiation to reduce the toxicity of BAK and its residues. The present study assessed the effect 
of UVC radiation on the toxicity and antimicrobial efficacy of BAK. The results 
demonstrated that BAK toxicity on HCEC can be completely eliminated with a proper dose 
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of UVC radiation, while the antimicrobial efficacy of BAK against P. aeruginosa was 
reduced simultaneously.  
PrestoBlue assay is a fast and highly sensitive assay in evaluating cell metabolic 
activity.20 The results of this assay demonstrated that the untreated BAK 0.01% and 0.005% 
were highly toxic to HCEC, and this toxicity was reduced by UVC radiation in a dose-
dependent manner. Several factors (the solution depth of BAK, well material, and time of 
assessment) that may affect the neutralization effect were also assessed. The neutralization 
effect on BAK 0.01% was significantly reduced by increasing the solution depth of BAK 
from 1.7 mm to 3.4 mm; whereas, this did not happen to BAK 0.005%. On possible reason 
for this difference is: there were more BAK molecules at 0.01% in 3.4 mm depth, and thus a 
greater amount of UVC was needed for a complete neutralization. This indicates that the 
concentration and the solution depth of BAK should be taken into consideration when 
determining the dose of UVC radiation to be used. Different well materials (polystyrene vs. 
polypropylene) and different time of measurement (0 h vs. 24 h after UVC radiation) showed 
similar neutralization effect. This result suggests that the neutralization effect is not affected 
by well material, and the neutralized BAK solutions do not regain their toxicity at 24 hours 
after UVC radiation.  
Based on the results of PrestoBlue assay, we further assessed the effect of UVC-
neutralized BAK on the cell viability of HCEC using confocal microscopy with fluorescent 
viability dyes. The cultures exposed to untreated BAK showed significant decrease in cell 
viability in a dose-dependent manner. In contrast, the cultures treated by UVC-neutralized 
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BAK demonstrated similar cell viability to the PBS control. This result suggests that the 
toxic effect of BAK on the cell viability of HCEC was also neutralized.  
Besides causing cell death, BAK is also known to destroy the barrier function of human 
corneal epithelium.20-22 A complete neutralization of BAK toxicity should also preserve the 
barrier function of HCEC. Tight junctions are intercellular junctional structures that are 
essential for epithelial barrier function. The components of tight junctions include 
transmembrane proteins (occluding and claudin), junctional adhesion molecules, and 
cytoplasmic proteins [such as zonula occludens (ZO)-1, ZO-2, and ZO-3].23 ZO-1 was the 
first protein localized to tight junctions24 and has been used extensively as a measurement of 
tight junctions.25,26 In the present study, we used immunofluorescence staining for ZO-1 to 
detect the damage of the barrier function caused by the test solutions. Intact cell junctions 
with regular distributions of ZO-1 were observed in the cultures exposed to PBS control and 
UVC-neutralized BAK 0.005% and 0.01%. In contrast, the expression of ZO-1 was greatly 
disturbed by the untreated BAK. This result further confirmed the neutralization effect 
observed in the assessments of metabolic activity and cell viability.  
It is suspected that UVC radiation may simultaneously reduce the antimicrobial activity 
of BAK. Thus, the antimicrobial activity of UVC-neutralized BAK against P. aeruginosa 
was also tested. The result showed the UVC- neutralized BAK 0.005% and 0.01% had little 
antimicrobial efficacy against P. aeruginosa in a 5 min disinfection time. This indicates that 
UVC radiation reduces BAK activity in both corneal epithelium and bacteria.  
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Based on the results of this study, the toxicity of BAK can be completely neutralized by 
appropriate doses of UVC radiation. The mechanism of this neutralization is not clear. It is 
likely that BAK absorbs the energy from UVC and undergoes a photochemical reaction that 
turns BAK into a non-toxic substance. The photochemical reaction is a chemical reaction that 
initiated by the absorption of energy in the form of electromagnetic radiation and ends with 
the formation of stable products that are different from the original chemical(s). In a 
photochemical reaction, a molecule absorbs energy from electromagnetic radiation and is 
promoted to an exited electronic state, thereby initiating a sequence of events that 
continuously lower the energy of the excited molecule. These events can include a number of 
bond-breaking and/or bond-making processes.27 The structure of BAK contains a benzyl 
group and a long alkyl chain (ranging from 8 to 18 carbon atoms).28 Several possible 
processes may occur to BAK upon absorption of the UV radiation: fragmentation of the long 
alkyl chain, cycloadditions of unsaturated benzene ring, and substitution reactions of the 
benzyl group. In these processes, the excited BAK species can fall apart, change to new 
structures, combine with each other or other molecules, and hence result in the formation of 
new chemicals (stable final products). In the current study, the final products formed in the 
photochemical reaction were stable and non-toxic. Further studies are needed to analyze the 
final products and to understand the mechanisms involved in this neutralization effect.  
BAK is particularly used by the food industry and hospitals for disinfecting surfaces and 
equipment.29,30 In the food industry, residues of BAK have been recently reported in a broad 
variety of fruits and vegetables, exceeding the default statutory maximum residue level 
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(MRL) of 0.01 milligrams per kilogram (mg/kg) in many cases.31 Conventional and organic 
produce were affected likewise. The residues might be caused by using BAK-containing 
disinfection products in food processing like washing, packaging and cleaning surfaces. In 
hospitals, BAK residues are also problematic. A few case reports have documented 
occupational asthma as a result of exposure to BAK.32-34 Allergic contact dermatitis to BAK 
in health care workers have also been reported.5 An even worse effect of BAK residues in 
hospitals is the development of bacterial resistance. A recent study demonstrated that the 
presence of BAK residues in polyethylene surfaces increased the bacteria’s ability to adhere 
to the surfaces and to develop biofilms, thereby could enhance resistance to sanitation 
attempts.35 Moreover, the concentration of BAK in hospital effluents and its associated 
environmental risk cannot be overlooked. Kummerer et  al. analyzed the BAK in complex 
effluent samples from different hospitals and reported concentrations of BAK up to 6.03 
mg/L.30 An increasing numbers of articles that emphasize the environmental concern of BAK 
have been found in the literature.28,36,37  
Based on the finding of this study, a disinfecting procedure using BAK and UVC in the 
food processing industries and hospitals may be of great value. BAK is a fast-acting biocidal 
agent that acts through membrane destruction.2,38 UVC is a non-chemical process which is 
environmental friendly. Its germicidal effects involve photochemical damage to ribonucleic 
acid (RNA) and deoxyribonucleic acid (DNA)39 by dimerization of pyrimidine molecules.40 
With the combination of BAK and UVC, two different antimicrobial mechanisms are utilized 
to maximize the disinfection effect; simultaneously, UVC neutralizes BAK residues at the 
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end of the disinfecting procedure and thus eliminates BAK’s potential hazards to human 
health and the environment. Therefore, this disinfecting procedure has a great potential to 
reduce the BAK residues in food products as well as to lower the bacterial disinfectant/drug 
resistance in hospitals.       
In conclusion, the present study revealed that BAK toxicity can be eliminated with a 
proper dose of UVC radiation. This finding provides a unique way of detoxifying BAK, and 
may be of great value in utilizing the antimicrobial efficacy of BAK with minimal potential 
hazard to human health and the environment. Further studies are needed to understand the 
mechanisms involved in this neutralization effect, and to develop practical protocols for its 
potential applications.  
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General conclusions 
As an alternative to animal ocular toxicity testing, an in vitro cell model using 
immortalized human corneal epithelial cells (HCEC) with different assays was developed. 
These assays include measurement of metabolic activity using PrestoBlue or alamarBlue, 
assessment of cell viability using confocal microscopy with fluorescent viability dyes, 
measurement of barrier function using sodium fluorescein, evaluation of tight junction 
proteins using immunofluorescence staining for zonula occludens (ZO)-1, and nuclear 
counterstaining with Hoechst 33342.  
The results presented in chapter 1 clearly revealed that the tested commercial ophthalmic 
solutions were less cytotoxic with new preservative than with BAK; and without preservative 
than with new preservative. This finding suggests that BAK-free, especially preservative-free 
ophthalmic solutions are safer alternatives to BAK-preserved ones. This study also 
demonstrated that the in vitro test battery had high sensitivity and correlated well with in vivo 
and clinical studies.    
The performances of three reagents – PrestoBlue, alamarBlue and MTT, in assessing cell 
viability of HCEC were compared in chapter 2. The result showed that PrestoBlue is more 
sensitive than MTT, but similar to alamarBlue. When fluorescence measurement was used, 
the plate color, reading mode and plate storage up to 7 days did not affect the performance of 
the PrestoBlue assay. This finding increases the flexibility of the PrestoBlue assay and offers 
more convenience to investigators.  
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Using the in vitro test battery with PrestoBlue, chapter 3 assessed the individual and 
combined toxicity of UV radiation and BAK on HCEC. The result proved that co-exposure 
to UV radiation and BAK can cause synergistic and additive effects on HCEC. This finding 
highlights the importance of considering the combined ocular toxicity of solar radiation and 
BAK in the risk assessment of BAK-preserved ophthalmic solutions.   
Mitigating the effect of toxic agents is of great importance in protecting humans from 
possible hazards. Chapter 4 demonstrated that the cell toxicity of BAK can be completely 
neutralized by appropriate doses of UVC radiation. This finding provides a unique way of 
detoxifying BAK, and may be of great value in utilizing the antimicrobial efficacy of BAK 
while minimizing its potential hazards to human health and the environment. 
In summary, the in vitro cell model developed in this research proved to be useful for 
assessing the corneal epithelial cell damage induced by ophthalmic solutions, BAK, and UV 
radiation; as well as for investigating the detoxification of BAK in vitro. This model may 
provide a sensitive and meaningful approach for evaluating both individual and combined 
ocular toxicity of UV and chemicals. 
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Appendix A.   
The Combined Ocular Toxicity of Chemical Mixtures and Chemicals 
plus UV Radiation 
Overview 
The human eye is often exposed both to sunlight and to variable combinations of 
different chemical compounds. Co-exposure to various toxic agents may produce a response 
that is equal, greater to or less than the sum of the individual toxicity. There are four kinds of 
toxicologic interactions between chemicals: additive effect, synergy, potentiation, and 
antagonism. Additive ocular toxicity has been shown in the combinations of xenobiotic 
chemicals with different functional groups. Exposure to disinfectants and their by-products 
can cause synergistic eye irritation. For example, certain viscosity-enhancing agents in 
ophthalmic solutions can potentiate benzalkonium chloride (BAK) - induced corneal damage. 
Antagonism has been used as the basis of many antidotes for poisons. Ozone depletion has 
increased the amount of solar ultraviolet (UV) radiation reaching the Earth’s surface, 
enhancing the risk of phototoxicity to the eye. When the eye is exposed to chemicals in the 
presence of UV radiation, some chemicals absorb the light, become excited to reactive states 
and provoke phototoxicity through a type 1 or type 2 reaction pathway; others do not react 
with the light but might produce stronger ocular toxicity when combined with UV; and 
certain agents such as antioxidants can protect the eye from UV damage. Potential additive 
and synergistic effects on the eye produced by exposure to chemical mixtures, or chemical 
plus UV radiation should always be considered in risk assessment procedures. 
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1. Introduction  
In daily life, human eyes are exposed to complex and variable combinations of different 
chemical compounds (i.e. personal hygiene products, air pollutants, make-up, skin care 
products, ocular and systemic mediations, etc). In most cases, exposures to each compound 
are below the toxic threshold level. However, interaction among chemicals may modify the 
magnitude and sometimes the nature of the toxic effect, producing stronger or weaker 
toxicity to the eye. Chemical interaction might occur in the toxicokinetic phase (such as 
processes of uptake, distribution, metabolism, biotransformation, and excretion) or in the 
toxicodynamic phase (such as effects of chemicals on receptors, cellular targets, or organs).  
Recently, the amount of solar ultraviolet (UV) radiation reaching the Earth’s surface has 
been increased due to the destruction of the ozone layer, posing an enhanced risk of 
phototoxicity to the eye, which can lead to impaired vision and even blindness. Some 
commonly used drugs, such as certain antibiotics, nonsteroidal anti-inflammatory drugs 
(NSAIDs) as well as some popular herbal medications, can act as photosensitizers and 
greatly enhance the ocular toxicity of UV radiation. Non-photosensitizing chemicals can also 
generate a stronger toxic effect to the eye in the presence of UV radiation.  
This article reviews the combined toxic effects of chemical mixtures, and chemicals plus 
UV radiation on the ocular and visual system. It also covers the basic concepts of the 
toxicological action of chemical mixtures, and mechanisms of chemical-induced ocular 
phototoxicity.  
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2. Combined Toxic Effects of Chemicals  
2.1  Basic concepts of combined actions of chemical mixtures  
The main goal of risk assessment of chemical combinations is to predict the toxicological 
effects of the mixture. The effects of co-exposure to different chemicals may produce a 
response that is equal, greater or less than the expected sum of their individual responses. 
These basic concepts of toxicological action of chemical mixtures have been defined by 
Loewe & Muischnek
1
, Bliss
2
 and Plackett & Hewlett
3
. 
2.1.1 No interaction  
There are two types of combined action without interaction: simple similar action and 
simple dissimilar action.  
Simple similar action:  A simple similar action occurs when the compounds act on the 
same biological site by the same mechanism and do not react to each other. The combined 
effect is equal to the sum of the effects of each agent given alone.  
Simple dissimilar action: In a simple dissimilar action, the chemicals act by different 
mechanisms, and may act on different biological sites. The presence of one chemical does 
not influence the effect of another chemical. Therefore, when the dose of each chemical is 
below the toxic threshold of the individual compounds, the combined toxic effect of all 
chemicals will also be below the toxic threshold.  
2.1.2 Interactions  
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Interactions among chemicals can occur in a variety of ways. They may occur in the 
toxicokinetic phase (such as during processes of uptake, distribution, metabolism and 
excretion) or in the toxicodynamic phase (such as effects of chemicals on receptors, cellular 
targets or organs). The results of interactions may be additive of their individual responses, or 
may be stronger (synergistic, potentiated) or weaker (antagonistic) than the sum of individual 
effects.  
Addition: An additive effect occurs when the combined effect of two chemicals is equal 
to the sum of the effects of each chemical given alone (i.e., 1+1=2).  
Synergistic effect: A synergistic effect occurs when the combined effect of two chemicals 
is greater than the sum of the effects of each chemical given alone (i.e., 1+1=10). 
Potentiation: Potentiation occurs when the toxicity of a chemical on a certain organ or 
system is enhanced when given together with another chemical that alone is not toxic to the 
same organ or system (i.e., 1+0=5). 
Antagonism: Antagonism occurs when the combined effect of two chemicals is less than 
the sum of the effects of each chemical given alone (i.e. 5+5=7, or 5+0 = 2). Antagonistic 
effects are the basis of many antidotes.  
2.2  Additive effect 
The additive effect is the most common mode of combined action of chemicals. Many 
medications have been reported to have the potential to cause additive ocular adverse 
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reaction when used in combination. These medications include but are not limited to 
cetirizine and antihistamines, Ginkgo biloba and warfarin or aspirin, vitamin A and other 
type of retinoids 
4,5
.  However, there are relatively few studies about the definite additive 
ocular toxicity of chemical combinations.    
Using the uptake of [3H]-uridine by mouse fibroblasts as a measurement, an in vitro test 
evaluated the ocular irritancy of 25 xenobiotic chemicals individually and in combination. 
The test compounds included alcohols, ethers, esters, ketones, amides, acids and a detergent. 
The result correlated well with the Draize test and indicated that combinations of agents with 
differing functional groups produce additive effects on ocular irritancy 
6
. 
The exposure of the eye to surfactants and detergents often causes various deleterious 
effects on the eye. Some surfactants, like ordinary soap, cause immediate eye irritation with 
little or no injury. Other surfactants produce corneal oedema and loss of corneal epithelium 
with no discomfort. Some cationic surfactants, e.g. benzalkonium chloride (BAK) and 
cetylpyridinium chloride, may cause immediate eye irritation as well as severe delayed 
effects on the corneal epithelium and stroma. Additive irritant effects on the eye were 
observed to various degrees in response to different solvents in combination 
7
.  
Airborne chemicals such as volatile organic compounds (VOCs) produce sensory 
irritation and the combined mixtures of VOCs play an important role in the perception of 
indoor air quality. Using a visual analogue scale and a comparative scale, one study 
conducted by Hempel-Jorgensen et al. assessed the ocular irritation caused by mixtures of 
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VOCs. It was demonstrated that three mixtures of VOCs interacted additively to produce 
ocular irritation 
8
. 
2.3  Synergy  
Many chemical combinations have been shown to cause synergistic toxic effects on the 
ocular and visual system.  
Exposure to a combination of disinfectants and their by-products can greatly enhance eye 
irritation. A study using the HET-CAM Test (Hens Egg Test at the Chorion Allantois 
Membrane) to investigate the mucous membrane irritating effect of halogenated carboxyl 
compounds (HCCs) demonstrated that, when combined with aqueous chlorine, a number of 
HCCs exhibited significantly enhanced effects. This result suggested that the eye irritating 
potential of swimming pool water is a consequence of the effects and synergistic action of a 
number of disinfection by-products in the presence of chlorine 
9
.  
Several surfactants such as BAK, cetylpyridinium chloride, and 
Ethylenediaminetetraacetic acid (EDTA) can increase corneal permeability and hence 
produce additive or synergistic effects when administrated together with other chemical 
compounds. Chang et al. tested the individual and combined toxicity of BAK and gentamicin 
on rabbit corneal epithelial cell membranes. They found that the presence of BAK synergized 
the effect of gentamicin on causing a leak in corneal epithelial cell membranes 
10
. Kikuchi et 
al. investigated the effects of EDTA plus boric acid on the corneal penetration of an anti-
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glaucoma agent (CS-088) and revealed that EDTA plus boric acid synergistically enhanced 
the corneal permeability of CS-088 via the transcellular pathway 
11
.  
Systemic medications can also interact synergistically to produce increased ocular 
adverse effects. A clinical study on patients with rheumatoid disease revealed that 
desferrioxamine and prochlorperazine were neurologically toxic and produced optic 
neuropathy and pigmentary retinopathy
12
. Subsequent in vivo/vitro studies conducted by the 
same investigators clearly demonstrated that the neurological effects were due to a 
synergistic action of desferrioxamine and prochlorperazine
12
.  
2.4 Potentiation  
Potentiation can occur through an alteration in the absorption, distribution, metabolism or 
excretion of a toxic compound, increasing the concentration and/or duration of the toxic 
compound in the target tissue or organ.  
Chemicals that prolong ocular contact time and increase intraocular drug levels have the 
potential to enhance the toxicity of other chemicals to the eye. One example is hydroxyethyl 
cellulose (HEC), a viscosity-enhancing agent in ophthalmic formulations. A previous study 
has shown that HEC potentiated BAK-induced corneal damage in rabbit eyes, by increasing 
the viscosity and prolonging the contact time of BAK with the cornea. Formulations with 
0.01% BAK and HEC caused corneal epithelial damage, but no damage occurred with the 
same concentration of BAK or with HEC alone 
13
.  
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Potentiation has also been shown to be one of the causes of cataracts and glaucoma. 
Using a mouse model, a report revealed that acetaminophen did not cause cataracts unless it 
was metabolized to N-acetyl-p-benzoquinone imine (NAPQI) in the liver, a process 
potentiated by cytochrome P450 enzymes 
14
. Another study showed that 5 beta-
Dihydrocortisol potentiated the threshold level (the smallest dose producing a measurable 
effect) of topically applied cortisol (0.02%) and dexamethasone (0.003%) in raising 
intraocular pressure. The author concluded that this potentiation may be responsible for the 
steroid sensitivity and for the ocular hypertension seen in glaucoma 
15
.   
2.5 Antagonism  
Antagonism of chemicals often produces beneficial effects in toxicology and is the basis 
of many antidotes. Extensive studies have demonstrated antagonist effects in reducing or 
eliminating the toxic effects of poisons, medications, drug additives and preservatives.  
N-3-pyridylmethyl-N'-p-nitrophenylurea (PNU) is a rodenticide that is also poisonous to 
humans. Gentamicin administered orally was shown to be an effective antidote for the ocular 
toxicity of PNU, with a speculated mechanism involving the killing of gastrointestinal 
bacteria responsible for transforming PNU into an ocular toxin 
16
. Cyanide is another poison 
which also has ocular toxicity. Bolaji et al. investigated the effect of lyophilized aqueous 
extract of Telfairia occidentalis (TO) on induced cyanide toxicity in rats and concluded that 
the extract had good potential as a safe antidote for cyanide poisoning 
17
. The potential 
mechanism is that TO extract facilitates the excretion of cyanide by offering a rich source of 
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sulphur to the mitochondrial enzyme rhodanese, which is responsible for converting cyanide 
into thiocyanate.  
Antagonism has also been used to decrease the ocular adverse effects of medications and 
preservatives in ophthalmic solutions. Recent work have demonstrated that caffeic acid 
phenethyl ester treatment may decrease the oxidative stress in the retina and optic nerve of 
isoniazid- and ethambutol-treated rats, and may prevent retinal ganglion cell (RGC) loss by 
an interaction with superoxide dismutase (SOD) 
18
. In glaucoma medications, sodium 
hyaluronate (a vehicle with antioxidation, moistening and lubricating properties) 
19
 has been 
shown to significantly decrease the ocular surface toxicity induced by BAK-preserved 
latanoprost and brimonidine in rabbits 
20,21
. 
Due to the extensive use of BAK as a preservative in ophthalmic solutions and its toxicity 
to the eye, substantial effort has been put into the development of antidotes for BAK toxicity.  
Latanoprost and travoprost were reported to have significant protective effects against BAK 
toxicity on conjunctiva-derived epithelial cells in vitro 
22
. Pauloin et al. investigated the 
effect of hyaluronan on the toxicity of BAK on two human epithelial cell lines in vitro. They 
found that high molecular weight hyaluronan (1000 kDa) significantly decreased oxidative 
stress, apoptosis and necrosis induced by BAK, and suggested that high molecular weight 
hyaluronan is an effective protective agent against BAK 
23
. Very recently, the ability of 
polyoxyethylene hydrogenated castor oil 40 (HCO-40) and polysorbate 80 (PS-80) to 
alleviate the corneal toxicity of BAK has been reported in an in vitro study with rabbit 
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corneal epithelial cells 
24
. However, the antibacterial effect of BAK was suppressed 
simultaneously.   
3. Combined Toxic Effects of Chemicals and UV Radiation 
3.1  Introduction  
Because of its specialized structure for focusing incoming light, the eye is  susceptible to 
light damage. Specific ocular disorders that can be caused by exposure to sunlight include 
photokeratitis, pingueculae and pterygia, uveal melanoma, cataracts, and macular 
degeneration. The spectrum of sunlight includes UV radiation (100-400 nm), the visual 
spectrum (400-700 nm) and infrared (700-10,000 nm). UV radiation has been subdivided into 
UVC (100–280 nm), UVB (280–315 nm), and UVA (315–400 nm). As already noted, due to 
the release of chlorofluorocarbons and nitrogen oxides in the stratosphere, ozone 
concentration has been reduced significantly in the past 30 years.
25
 Ozone depletion increases 
the amount of UVB solar radiation reaching the Earth’s surface, which leads to a higher risk 
of phototoxicity in the eye.  
UV radiation-induced ocular damage can be attributed to two mechanisms; 1) direct 
process in which the radiation is absorbed by specific naturally occurring chromophores 
(such as the nucleic acids or aromatic amino acid residues) within the eye; and 2) indirect or 
photosensitized process when the radiation is absorbed by a photosensitizing agent or other 
extraneous compound, which then become excited to reactive state and damages the ocular 
tissues through producing free radicals and reactive oxygen species 
26
.   
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Exposing the eye simultaneously or consecutively to a chemical and UV radiation may 
generate a combined toxic effect, which is greater, less, or equal to the sum of their 
individual toxicity. Chemicals may serve as photosensitizers to enhance the toxicity of UV 
(phototoxicity), or act synergistically with UV to produce much greater ocular toxicity, or 
may protect the eye from UV damage.  
3.2  Phototoxicity  
3.2.1 Mechanisms  
Phototoxicity can be produced by the presence of photosensitizing agents. Chemicals 
absorb the incident light, become excited to reactive states, and then interact with substrate 
molecules through two principal reaction pathways, one involving direct free radical 
reactions (Type 1), and the other involving production of reactive oxygen species (ROS) 
(Type 2) 
27
.  
In the Type 1 reaction, the chemical is excited by light to a triplet state and undergoes a 
direct electron or hydrogen exchange with a substrate, creating a free radical intermediate. 
This free radical reacts with an available substrate to create peroxidation reaction products. In 
contact, in the Type 2 reaction, the excited chemical directly transfers energy to oxygen and 
creates reactive singlet oxygen. Singlet oxygen reacts with lipids to create peroxides without 
a free radical intermediate, or it can react with other substrates to generate reactive free 
radicals 
27
. The free radicals and ROS can cause oxidative damage to lipids, proteins, 
mitochondria, DNA, and so on.   
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3.2.2 Photosensitizers 
Whether a chemical is capable of producing phototoxicity in the eye depends on several 
factors, including the chemical’s structure, it’s absorption spectra, its capability to bind to 
ocular tissue, and its ability to cross blood-ocular barriers (this last factor applies only to the 
systemic medications) 
28
. Any compound that has a tricyclic, heterocyclic or porphyrin ring 
structure is a potential photosensitizer. Many commonly used drugs and chemical compounds 
have known or potential photosensitizing properties on the eye. These drugs include 
fluoroquinolone antibiotics (Levofloxacin, Lomefloxacin, etc.) 
26,29
, diagnostic dye 
30
, 
antimalarial medication (chloroquine) 
31
, nonsteroidal anti-inflammatory drugs (NSAIDs) 
(Ketoprofen, piroxicam, etc.)
32
, psoralen 
31
, and psychotherapeutic agents 
31,33
, as well as 
some herbal medicines 
34
. The action spectrum for most of them includes UVA and the visual 
spectrum, with the cornea and lens being their most common potential targets. 
3.2.3 Examples of chemical induced phototoxicity   
Psoralen has been well known for its photosensitizing property. Photosensitization 
damage to the lens and retina with psoralen plus UV radiation (320-400 mm) (PUVA) has 
been demonstrated in experimental animals, as well as in clinical report on patients given 
PUVA therapy 
35
. The effects of various psoralen derivatives and UVA radiation have also 
been studied 
36
. Barker et al. tested the ocular toxicity of acute administration of 8-
methoxypsoralen (8-MOP), 5-methoxypsoralen (5-MOP), and 3-carbethoxypsoralen (3-CPS) 
with and without 0.2 or 48 J/cm
2
 UVA radiation in a mouse model. Ocular damage 
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consisting of dense central corneal opacification was seen at significant levels in animals 
given 8-MOP or 5-MOP and exposed to UVA, but not in animals given derivatives or UVA 
alone. The mechanisms of damage were not addressed.   
Using in vitro models, the ocular phototoxicity of diagnostic dye, certain antipsychotic 
medications and antibiotics have been evaluated. Hull and his colleagues assessed 
photosensitization of a diagnostic dye and three antipsychotic medications on corneal 
endothelium cells 
30,37-39
. They found that Rose Bengal 
30
, chlorpromazine 
37
, trifluoperazine 
38
 and hematoporphyrin derivative (HPD) 
39
 were all able to induce corneal endothelium 
phototoxicity in vitro.  Endothelium swelling was a manifestation common to all. Persad et 
al. investigated the cytotoxic effects of UV-visible irradiation on retinal pigment epithelial 
(RPE) cells in the presence of chlorpromazine. They found that the phototoxic effect of 
chlorpromazine was due to stable photoproducts formed during light irradiation, and this 
occurred at low concentrations (5ug/ml) of chlorpromazine. Vitamin E was able to decrease 
the phototoxicity both in the dark and upon irradiation. Hypericin is one of the bioactive 
ingredients of a medication for depression in Europe. A recent study investigated the 
photooxidative damage of hypericin on α-crystallin in human lens epithelial cells and 
detected extensive polymerization of α-crystallin exposed in vitro to hypericin and UVA 34. 
Another in vitro study tested the photosensitization of Levofloxacin under the ambient 
environmental intensities of UV-A, UV-B and sunlight exposure and revealed that 
photosensitized Levofloxacin caused lipid peroxidation, significantly reduced cell viability, 
and induced upregulation of p21 and Bax ⁄ Bcl-2 genes ratio 2639.  
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Fish eyes are uniquely vulnerable to environmental stress. The effect of polycyclic 
aromatic hydrocarbons (PAHs) on the optical properties of Rainbow Trout lenses in the 
presence or absence of UV radiation was evaluated by Laycock and his colleagues 
40
. They 
found that simultaneous exposure to UV and PAHs damaged rainbow trout lens membranes 
and increased focal length variability (FLV); whereas UV and PAHs alone did not cause this 
damage. The speculated mechanism is that the PAHs accumulate in lens cells membranes, 
and upon absorbing radiation, undergo chemical reactions that generate ROS and cause cell 
membrane disruption.  
3.3  Synergistic effect of UV radiation and chemicals  
Some chemicals do not absorb UV radiation; however, their toxicity is greatly enhanced 
when combined with UV radiation.  
One in vitro study assessed the toxic and mutagenic potential of four commonly used 
ophthalmic preservatives (BAK, chlorhexidine, thimerosal and ethylenediaminetetraacetic 
acid) in the presence and absence of UVA radiation. The result demonstrated that UV 
radiation synergistically enhanced the mutagenic activity of chlorhexidine and thimerosal. 
Chlorhexidine alone had little effect on the mutation rate, but when combined with UVA 
exposure, there was approximately a three fold increase over background in the numbers of 
mutants. Thimerosal by itself appears to be weakly mutagenic. When cells were exposed to 
thimerosal plus UVA treatment there was about a six-fold increase in the number of mutants 
over the control value 
41
. In another study with primate eyes, Zuclich et al. demonstrated that  
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eyes that were moistened with a wetting solution containing BAK had lower thresholds for 
damage by a krypton laser (350-360 nm) than eyes that were not premoistened before 
exposure to laser radiation
42
. 
3.4  Protective effect of chemicals against UV radiation  
Some chemicals have been found to have protective effect against UV damage to the eye. 
Quercetin is a well knows antioxidant. Researchers speculate that quercetin may have a role 
in protecting lens cells against UV-induced damage. In a recent in vitro study using human 
lens cells, Jiang et al. showed that quercetin protected against a UV- and H2O2-induced 
decrease of collagen type I in a dose-dependent manner 
43
. Quercetin also protects human 
lens cells from damage resulting from other toxic chemicals 
44
. Hyaluronic acid (HA) is 
another useful tool to protect the skin and the eye against UV radiation. The ability of HA in 
protecting the eye from UV radiation has been demonstrated in a recent study 
45
. When 
human corneal cells were exposed to HA before exposure to UVB radiation, hyaluronic acid 
protected the cells against UVB radiation-induced inflammation and apoptosis. Some 
nutrients like bilberry’s (Vaccinium myrtillus) flavonoid components, the amino acid taurine 
and N-acetyl cysteine are also shown to improve the health of the eye and protect against 
cataracts formation 
46-48
.  
4. Conclusion  
Human eyes are exposed to UV radiation and various chemicals on a daily basis. Many 
chemical combinations have been shown to cause enhanced ocular toxicity through 
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synergism, addition, or potentiation. With better understanding of the ocular pototoxicity of 
UV radiation and chemicals, more and more medications and chemical compounds with 
known or potential ocular photosensitizing property have been identified. However, there are 
relatively few studies on the combined effect of UV radiation and non-photosensitizing 
chemicals on the eye. Many of the mechanisms of combined toxicity are still unknown. Most 
risk assessments are based on individual ocular toxicity. More attention should be paid to the 
combined effects and to the efforts to understand the mechanisms of co-exposure.  
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